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ABSTRACT 
 
Selected Studies on Avian RNA Viruses. (2010) 
Itamar Davi Schabert Villanueva, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Ian Tizard 
 
There are many pathogens that infect birds and perhaps many more that 
researchers have not yet identified.  Of all potential pathogens, the research presented in 
this manuscript focuses on two avian RNA viruses.    
First, a serodiagnostic test for newly described Avian Borna Virus (ABV), which 
has been recently identified as the etiological agent of Proventricular Dilatation Disease 
(PDD), was developed.  PDD is a deadly disease which affects many birds, but to this 
point, has mainly been a concern of psittacines. The need for a diagnostic test is 
imperative.  An antigen associated with PDD was identified from the brains of affected 
birds by use of the Western blot assay.  This antigen was subsequently purified using 
various protein purification protocols, including a modification of reverse-phase 
chromatography.  The antigen was then identified as the ABV nucleoprotein according 
to tandem mass spectroscopy analysis and protein database search.  A serodiagnostic 
assay was developed and standardized using infected cell culture as an antigen source.  
Over 100 avian serum samples were submitted by veterinarians to test for the presence 
of antibodies against ABV nucleoprotein.  This serodiagnostic assay was found to have 
90% sensitivity and 82% specificity for the diagnosis of ABV in infected birds. 
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 Second, the ability of a carbohydrate epitope to enhance the humoral immune 
response to an influenza vaccine was tested in chickens.  Influenza is a serious infection 
that causes 36,000 deaths annually in the United States.  The need for a more efficacious 
is addressed by incorporating a carbohydrate antigen targeted by natural antibodies that 
are produced by chickens as well as humans.  Therefore, chickens may be a suitable 
animal model to test this hypothesis.  Influenza vaccines with alpha-gal antigen are 
prepared from cell culture.  The antigen is then enzymatically removed from some 
vaccines and the nature of the ensuing humoral immune response to these vaccines in 
chickens is attempted.  
Though ABV is not known to be zoonotic at this time, zoonotic infections pose 
the highest risk as new and emerging infectious diseases in the human population.  The 
following research contains applications relative to challenges faced by researchers and 
clinicians in infectious disease containment. 
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CHAPTER I 
 
AVIAN BORNA VIRUS 
 
1.  Introduction 
Borna disease is a condition which was most likely first characterized in the late 18
th
 
century in southeastern Germany.  Published in a veterinary handbook, the author correctly 
described the clinical symptoms of Borna disease in horses and attributed the condition to 
unsatisfied sexual desire or overfeeding.  It was recommended, among other things, to thread a 
rope covered in Spanish fly through the subcutaneous tissues of the patient (Kaprowski, 1995).  
A second account was recorded in 1885 in Borna, Saxony, Germany where horses in a cavalry 
regiment suffered deaths due to a neurologic disease.  The horses presented with behaviors such 
as abnormal head movements, walking into walls and being unable to chew food (Keizo, 2002).  
Despite the long history of this disease, much remains to be understood about the nature, 
infectivity, and molecular pathogenesis of the etiologic agent, named Borna Disease Virus 
(BDV).  The virus has been found to cause serious neurologic disease in some hosts, and yet not 
cause any clinical symptoms in others.  The virus adds to this enigma by its slow growth in cell 
culture, noncytolytic property, and ability to establish lifelong chronic infection.   Throughout 
the literature, Borna Disease Virus (BDV) is the name of the virus that, regardless of host, causes 
a neurological disease which affects behavior and coordination.  The recent discovery of a new 
type of BDV, Avian Borna Virus (ABV), is currently known to be limited to avian species and 
has been associated with a disease that is specific to birds.  
 
This dissertation follows the style of Veterinary Microbiology.  
 2 
 
Proventricular Dilatation Disease (PDD) is a disease specific to the avian gastrointestinal system 
and therefore unable to be duplicated in a mammalian system due to anatomical differences.  
However, evidence indicates that the nervous system of both birds and mammals may be 
similarly affected by ABV and BDV, respectively.  In this regard, both viruses cause similar 
diseases.   For clarity, the term Borna virus (BV) in this manuscript will be given to the 
mammalian Borna virus known to cause Borna Disease in susceptible hosts.  The term Avian 
Borna Virus (ABV) will be given to the virus that causes PDD in susceptible birds.                                 
2.  Host Range and Epidemiology 
BV has a broad host range and presumably just as broad a geographical range.  The 
presence of borna virus infection, or exposure, is confirmed by presence of viral ribonucleic acid 
(RNA) and/or antibodies to BV antigens.  Antibodies and/or RNA to BV have been detected in 
psychiatric patients in Japan, as well as clinically healthy Japanese individuals (Haga et al., 
1997a; Haga et al., 1997b; Kishi et al., 1995; Matsunaga et al., 2008).  Evidence of BV infection 
has also been demonstrated in sheep, horses, cats, cattle, and recently raccoons (Hagiwara et al., 
1997; Hagiwara et al., 2009; Hagiwara et al., 1996; Nakamura et al., 1996; Nakamura et al., 
1995).  Australia has reported evidence of Borna virus infections in humans as well as cats, but 
not in horses (Flower et al., 2008; Kamhieh and Flower, 2006; Kamhieh et al., 2006; Kamhieh et 
al., 2008).  Investigators have demonstrated evidence of borna virus infection in ostriches and 
farm workers in ostrich farms in South Africa and Israel (Verwoerd, 2000; Weisman et al., 1994; 
Wormser et al., 1996).  Individuals with psychiatric disorders and clinically healthy individuals 
were found to have antibodies against BV phosphoprotein in Brazil (Miranda et al., 2006).  In 
the United States, patients with neurological disease were found to be seropositive for BV by 
indirect immunofluorescent assay in a study conducted in the early 1980s (Amsterdam et al., 
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1985; Rott et al., 1985).  Additionally, the presence of Borna virus was also determined to be in 
such varied hosts as deer, primates, sloths, alpacas, llamas and hippopotami (Ernst, 1927; Ikuta, 
2002; Zwick, 1939).  Chickens have been shown to be susceptible to experimental infection with 
borna virus (Ludwig et al., 1973).  In light of these findings, it seems appropriate to conclude 
that Borna virus has a world-wide presence and has an extremely broad host range in warm 
blooded animals.  It seems as if BV has been found almost wherever its presence was sought.  
Because the disease has been found in such a diverse group of hosts, it seems difficult to 
speculate about the natural host of this virus.  However, researchers have suggested that the 
reservoir host may be the shrew, Crocidura leucodon. The shrews were found in an area where 
BV was endemic and harbored the virus without any detectable histopathologic signs of infection 
(Hilbe, et al., 2006).  One controversial topic is BV‟s ability to cause disease in humans.  The 
literature suggests that humans have been infected with BV because of the detection of 
antibodies and RNA specific for BV.  However, BV infection in humans has been associated 
with varied neurologic conditions thereby making it harder to establish this virus as the etiologic 
agent of these diseases.  The fact that BV has also been detected in clinically normal human 
patients adds to the mystery.  Detection of BV in human patients by PCR has been put in 
question because the technique falls victim to its own strength.  As the sensitivity of the PCR 
assay increases, so does the probability that the sample tested was contaminated.  False positive 
results are always of great concern given the virus‟ remarkable genetic conservation.  
3.  Molecular Biology of Borna Virus  
Borna virus is an enveloped, nonsegmented, negative-sense, single stranded RNA virus 
and the prototype member of the family Bornaviridae in the order Mononegavirales.  Other 
members of this order include Filoviridae, Paramyxoviridae, and Rhabdoviridae.  Borna virus 
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distinguishes itself from other members in the order Mononegavirales because it replicates in the 
nucleus, specifically, in the nucleolus (Cubitt et al., 1994; Pyper et al., 1998). Because of its 
intranuclear replication, BV has the ability to utilize cellular splicing proteins in order to 
alternatively splice viral mRNA and is able to use different initiation codons to transcribe 
overlapping open reading frames that allows for the production of a wide variety of proteins 
(Briese et al., 1994; Schneider et al., 1994; Tomonaga et al., 2000). The BV genome codes for at 
least six proteins of which the function has been at least partly characterized.  These include the 
L-polymerase (L, 190 kDa), the glycoprotein (G, 57 kDa) two isoforms of the nucleoprotein (N, 
38kDa and 40kDa), the phosphoprotein (P, 23kDa), the matrix protein (M, 16 kDa), and the 
more recently characterized X protein (X, 10 kDa) (Hornig et al., 2003).  Expression of the L 
protein, the BV polymerase, provides the prototypical example of alternative splicing.  In the 
third transcription unit of the BV genome, fusion of a small upstream open reading frame with a 
larger downstream continuous open reading frame produces the polymerase protein of 
BV(Keizo, 2002).  The L protein has a nuclear localization sequence, is phosphorylated, and 
interacts with P protein in a fully functional ribonucleoprotein (RNP) complex (Walker et al., 
2000; Walker and Lipkin, 2002).  The glycoprotein (G) of BV is thought to mediate viral entry 
into the host cell by clathrin mediated endocytosis (Clemente and de la Torre, 2009).  The G 
protein is heavily glycosylated and is cleaved into GP1 and GP2 by the cellular enzyme furin 
(Bajramovic et al., 2003; Clemente and de la Torre, 2007).  Though the molecular weight of the 
non-glycosylated G protein is about 57 kDa, extensive glycosylation causes the molecular weight 
to increase to 84-94 kDa (Clemente and de la Torre, 2009).  GP1 has been shown to be sufficient 
for viral entry in to the host cell, whereas GP2 is thought to mediate pH dependent fusion 
between the virus and cellular membranes (Gonzalez-Dunia et al., 1998; Perez et al., 2001).  
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Interaction between the G protein and a cellular receptor for viral entry into the host cell has not 
been demonstrated, but it is speculated that the G protein may interact with a member of the 
glutamate receptor family (Hornig et al., 2002).  The N protein is the main target of both the 
humoral and cellular immune response. Nucleoprotein is also the most abundant protein in BV 
infected cell culture and in experimentally infected animals (Keizo, 2002) .  The two isoforms of 
BV nucleoprotein are 38 kDa and 40 kDa.  The production of these two isoforms may result 
from two different mRNA species, or from differential usage of inframe initiation codons in the 
BV N gene (Pyper and Gartner, 1997).  The N protein is responsible for binding viral RNA to 
form the ribonucleoprotein (RNP).  The 38kDa isoform of the BV N protein is able to transport 
the infectious RNP into the cytoplasm of the infected cell.  The 40 kDa isoform not only contains 
a nuclear export signal, it also contains a nuclear localization signal so that it is transported back 
into the nucleus (Kobayashi et al., 2001).  The 40kDa is also the only isoform of the N protein 
that is able to support replication and transcription in studies undertaken with a BV minigenome 
(Schneider et al., 2004b). Crystal structures of the BV N protein show oligomerization of the 
protein and RNA binding domains that are similar to other negative-sense RNA viral 
nucleoproteins of influenza and two rhabdoviruses (Luo et al., 2007; Rudolph et al., 2003).  The 
BV phosphoprotein is responsible for regulation of the active viral nuclear polymerase by 
interaction with the N, L, and X proteins (Poenisch et al., 2004; Schneider, 2005).  P protein is 
also involved in encapsidation of viral RNA (Schneider, 2005).  Like the N protein, the P protein 
has an isoform termed P‟ that is the result of differential usage of initiation codons in BV 
infected cell cultures.  However, the P‟ isoform does not seem to play an active role in 
supporting viral replication (Schneider et al., 2004a).  More recently, P protein was found to 
interact with gamma-aminobutyric acid receptor-associated protein (GABARAP) in infected cell 
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culture.  GABARAP plays an important part in regulation of gamma-aminobutyric acid, an 
important neurotransmitter.  The interaction between GABARAP and P protein may shed light 
on the manipulation of the neuronal network by BV proteins (Peng et al., 2008) .  The matrix 
protein has been reported to be part of the RNP complex, but its role in viral RNA transcription 
is under investigation (Mayer et al., 2005).  BV M protein has been shown to interact with the P 
protein, but not other proteins in the RNP complex. Unlike the matrix proteins of other viruses 
such as influenza and respiratory synctial virus that serve to negatively regulate viral 
transcription, the BV M protein seems to enhance viral transcription without interference of the 
viral polymerase (Chase et al., 2007).  The matrix protein of a similar virus, measles virus, was 
shown to regulate viral transcription via interaction with the measles nucleoprotein (Iwasaki et 
al., 2009).  Single-strand RNA binding properties have been described in the crystal structure of 
the BV M protein.  With a structure similar to Ebola virus matrix protein, the BV M protein is 
able to bind single stranded RNA and lipid structures, presumable lipid membranes (Neumann et 
al., 2009).  Lastly, the non-structural X protein has been shown to negatively regulate viral 
polymerase function through interaction with P protein and perhaps indirect contact with N 
protein via the P protein (Perez et al., 2003; Poenisch et al., 2004; Schneider et al., 2003).   The 
X protein has been shown to serve as a buffer against the effects of P protein interaction with N 
protein during viral replication (Poenisch et al., 2008).  As will be shown later, the ratio of N 
protein to P protein in the nucleus regulates the rate of viral replication.  Other possible functions 
of the X protein include interaction with heat shock cognate protein 70 as a means to translocate 
in and out of the nucleus and ability to inhibit cellular apoptosis (Hayashi et al., 2009; Poenisch 
et al., 2009).    
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4.  Viral Life Cycle 
The life cycle of BV is one that has seen significant advances in recent years, but details remain 
to be elucidated.   The cycle of infection is suspected to occur in a similar manner as other 
members of the order Mononegaviradae with a few important exceptions, most notably 
replication in the nucleus.  Borna virus is noncytopathic and able to infect primarily neuronal 
cells including astrocytes, oligodendrocytes, and Schwann cells as well as peripheral blood 
mononuclear cells (Hatalski et al., 1997; Koprowski, 1995; Richt et al., 1997; Sierra-Honigmann 
et al., 1993).  Cell culture lines susceptible to BV infection include MDCK, Vero cells and L929 
cells (Koprowski, 1995).  Viral entry into the host cell is mediated by G protein attachment to an 
unknown cellular receptor followed by endocytosis into the host cell via a clathrin mediated, 
caveola-independent pathway (Clemente and de la Torre, 2009).  The receptor for BV entry into 
the host cell is thought to belong to the glutamate family, although this has been disputed 
(Hornig, et al., 2002; Richter, et al., 2009).  The viral G protein attaches to its receptor and is 
cleaved into gp56 and gp43.  It is thought that gp56 mediates the attachment to the cellular 
receptor and gp43 mediates pH dependent fusion to the cellular membrane in order to release the 
ribonucleic protein (RNP) complex into the cytoplasm (Gonzalez-Dunia, et al., 1998).  The 
genomic and anti-genomic RNA are neither capped, nor polyadenylated, and therefore exist as 
infectious RNP complexes (de la Torre, 1994).  The RNP complex is targeted for import into the 
nucleus by the nuclear localization sequences encoded in the N, P, and L proteins.  The X and M 
proteins are also targeted to the nucleus via nuclear localization sequences. However, it is not 
known whether these proteins enter the nucleus as part of the RNP, or if they bind to the RNP 
complex once in the nucleus.  Transcription of the polycistronic genome is carried out from the 
3‟ to the 5‟ end by the polymerase complex, consisting of the N, P, L, X, proteins and perhaps 
 8 
 
the M protein.  One proposed mechanism for viral transcription is “cartwheeling” where the P 
protein provides the “legs” upon which the polymerase (L) protein rests.  The P protein then 
“walks” on the N proteins with simultaneous making and breaking of bonds with the N protein 
while the L protein transcribes the viral RNA (Curran, 1998; Schneider, 2005).  Transcription is 
regulated stoicheometrically by the ratio of N to P.  It is proposed that the optimal ratio of N to P 
for efficient transcription is 1:20; a ratio of 1:1 completely abolishes viral transcription 
(Schneider et al., 2003).  However, it was shown that addition of the 38 kDa isoform of the N 
protein to an infected cell could reactivate transcription in unfavorable N to P ratios (Schneider 
et al., 2004b). The P protein is able to inhibit N protein from exiting the nucleus by masking its 
nuclear exit signal and serves as another method of viral transcriptional regulation.  The N 
protein, and perhaps the RNP complex, exits the nucleus through the CMR1-dependent pathway 
(Kobayashi et al., 2001).  CMR-1 is a nuclear export receptor that carries proteins, such as the 
HIV Rev protein, through nuclear pores and into the cytoplasm (Stutz and Rosbash, 1998).  
Though both isoforms of the N protein contain a nuclear export sequence, only the 40 kDa 
isoform contains a nuclear localization sequence and is thus targeted back to the nucleus for 
further rounds of transcription (Kobayashi et al., 2001).  The process of BV virion assembly is 
currently unknown, but researchers reported cytoplasmic enveloped viral particles 50-100 nm in 
infected cells that were morphologically similar to partially purified BV virions (Compans et al., 
1994).  Borna virus is thought to infect cells in a manner similar to that of rabies virus in that the 
RNP complexes spread along the neuronal networks inside axons.  However, unlike rabies virus, 
fully formed BV particles have not been visualized along neuronal networks (Carbone et al., 
1987; Gosztonyi et al., 1993).  Several investigators have been successful in visualizing virus-
like particles from cell cultures infected with BV by adding sodium butyrate to the cell culture 
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media.  The addition of sodium n-butyrate (6-10mM) is known to inhibit cell division and is 
thought to produce conditions in which viral RNA transcription is favored over cellular RNA 
transcription (Kohno et al., 1999; Pauli and Ludwig, 1985).  Amantadine has been proposed as a 
drug that could be used as treatment for BV infection.  However, the mechanism of the drug and 
its efficacy are still a topic of debate (Cubitt and de la Torre, 1997; Gonzalez-Dunia et al., 1998; 
Ludwig and Bode, 2000; Stitz et al., 1998b).  
5.  Animal Models of Borna Virus Disease 
 Borna virus has a broad host range and therefore has allowed investigators to use several 
animal models for experimental infection.  Some animal models used to study BV pathogenesis 
include chickens, mice, rabbits, rhesus monkeys, and shrews with the rat serving as the most 
common animal model in BV research (Keizo, 2002).  Borna disease has an acute phase in most 
animal models which include hyperactivity, aggression, large appetite, priapism, and 
incoordination.  The chronic phase is characterized by a docile and passive attitude in infected 
animals that may turn abruptly, but temporarily, aggressive when disturbed (Pletnikov, 2002).  
These clinical symptoms correspond with the pathology of the acute and chronic phases of Borna 
disease.  Namely, the acute phase is characterized by a high degree of encephalomyelitis 
followed by a chronic phase with reduced inflammation without a decrease in viral antigen 
(Gosztonyi and Ludwig, 1995).   As with most viruses, the clinical and pathological 
manifestation of BV infection depends on such variables as strain type, immune status of the 
host, and age among other things.  For example, adult rats that are infected with BV tend to have 
an acute and sometimes fatal encephalitis.  Rats infected with BV at 5 to 6 weeks of age are 
found to demonstrate aggressive and neurotic behavior such as biting of cagemates, and have 
“ravenous appetites” at about 20 to 30 days post-infection.  After the initial symptoms of disease 
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subside at about 50-60 days, rats became subdued and depressed as neuronal cell death occurs.  
The pathology of these rats corresponds with their clinical behavior in that there is a significant 
mononuclear inflammatory immune response primarily in the cerebral cortex, hypothalamus, and 
thalamus up to 20-30 days post infection (Narayan et al., 1983a).  During the chronic phase of 
the disease, progressive cellular death is observed as the virus spreads from the hippocampus and 
frontal cortex to the hypothalamus, particularly the dentate gyrus, and all over the central 
nervous system and the spinal cord, including the ganglia of the spinal cord (Carbone et al., 
1987; Jordan and Lipkin, 2001).  Infection of neonatal rats results in chronic viral presence in the 
brain.  Neonatal rats infected with BV exhibit a limited pro-inflammatory response, abnormal 
development of the cerebellum and hippocampus, retarded growth and antisocial behavior that is 
similar to autism spectrum disorder (Hornig et al., 2001; Hornig et al., 1999; Rubin et al., 1999)  
Because of the similarity that Borna disease in rats shares with autism, BV infection of neonatal 
rats is often used to study the possibility that autism may be virally induced, resulting in 
disruption of proper neuronal development, including imbalances of neurotransmitters such as 
serotonin and dopamine (Heimrich et al., 2009; Hornig et al., 2002).  Immunosuppressed rats 
that are infected with BV have the same outcome as those that are infected neonatally with one 
important difference: neonatally infected rats are still able to mount a humoral response to BV 
antigens (Narayan et al., 1983b).  The humoral immune response in hosts is thought to limit viral 
replication from spreading to non-neural tissues (Stitz et al., 1998a).  Borna infection in rhesus 
monkeys tends to have the same pathology and clinical symptoms as BV infected rats.  Just as in 
rats, immunopathology seems to be driven by T cells, more specifically cytotoxic CD8 T cells, 
infection is restricted to neural cells, and splenectomized test subjects tend to have a milder form 
of encephalomyelitis (Baur et al., 2008; Bilzer et al., 1995; Stitz et al., 1981).   Of 13 day-old 
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chicks infected intracerebrally with rabbit brain homogenate containing BV, all suffered 
paralysis of the wings and feet and became ataxic.  Four of the 13 chickens were able to recover 
from the disease after suffering mild paralysis (Ludwig et al., 1973).  Borna virus is uncommon 
in that it is able to establish a persistent chronic infection if the host survives the acute phase of 
the disease.  The ability of BV to establish a persistent neurological infection makes it similar to 
agents such as lymphocytic choriomeningitis virus, herpesvirus, and the transmissible 
spongiform encephalopathies.  How an RNA virus is able to do this is of interest.  One 
hypothesis is that BV is able to trim its genome in such a manner that the 5‟ termini of viral RNA 
contain monophosphate instead of triphosphate motifs so as to avoid detection by the host 
pattern-recognition receptor retinoic acid inducible gene (RIG-1), and thus triggering an immune 
response against the virus (Schneider et al., 2007).  Recently, it has been shown that 
coxsakievirus, an RNA enterovirus, is able to establish chronic infection in the central nervous 
system by perhaps trimming its genome into a non-virulent form of the virus.  Researchers were 
also able to show that coxsakievirus RNA from mouse brain homogenates was able to infect cell 
cultures (Feuer et al., 2009).  Perhaps this may offer a clue as to how BV is able to establish a 
chronic infection in the nervous system.    
6.  Immune Response to Borna Virus  
 The adaptive immune response plays the dominant role in the host response to BV 
infection.  More specifically, BV infection causes T-cell mediated immunopathology on the host 
nervous system due to the inability of the host to clear BV and due to inefficient major 
histocompatability class (MHC) presentation by neurons (Baur et al., 2008; Hart and Fabry, 
1995; Joly et al., 1991).  However, some researchers argue that astrocytes, in addition to 
microglial cells, are competent antigen presenting cells (Fontana et al., 1984)  In animal 
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experimental models, the virus has a propensity to replicate in cells from the neural crest such as 
neurons, astrocytes and ependymal cells and tends to spread throughout the central nervous 
system (Carbone et al., 1991; Stitz et al., 1995).  Histopathology of BV infection shows 
perivascular cuffing consisting of T cells, macrophages and B cells (Deschl et al., 1990).  During 
the acute phase of Borna disease, inflammatory cells infiltrate neural vessels to form perivascular 
cuffs.  During the chronic phase of Borna disease, the numbers of these inflammatory cells 
decrease and the histopathology resembles a “burned out” encephalitis.   Cytotoxic CD8 T cells 
play a substantial role in immunopathology by causing lesions due to cell death in the brain of 
hosts infected with BV (Bilzer and Stitz, 1994; Planz et al., 1995; Stitz et al., 1993).  These 
lesions appear to be IFN-γ mediated and may not require antigen presentation by MHC (Baur et 
al., 2008; Hausmann et al., 2005).  Though cell death may be driven by cytotoxic T cells, 
evidence exists that IFN-γ may have a protective effect on bystander cells (Richter et al., 2009).  
BV, and/or the resulting immune response, in concert with proinflammatory cytokines is 
somehow able to enhance T cell trafficking across the brain paremchyma (Baur et al., 2008). 
CD4 cells play a less prominent role in BV immunopathology than do CD8 T cells.  An 
exception is noted in immunosuppressed rats experimentally infected with BV.  Rats died 
without neurological symptoms and drastic weight loss as early as 5 days after injection of 
effecter CD 4 T cells (Planz et al., 1995).  Antibodies designed to minimalize CD4 T cell activity 
during BV infection have minimal effects on the resulting encephalitis and merely delay the 
disease process (Noske et al., 1998; Pletnikov, 2002).  Research into the role of T cells in the 
immunopathology of BV has mainly focused on CD4 and CD8 Tcells and has not addressed the 
role of other T cell subsets.  Some papers did not account for the fact that T helper 1 cells have 
cytotoxic activity.  Furthermore, little research has been performed on the role of regulatory T 
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cells.  It is unquestioned that BV neurodegeneration is mediated by T cells.  However, the fact 
that the virus is able to replicate in chronic Borna disease with a reduction of inflammatory cells 
suggests that immunoregulation is at work.  In HIV-mediated neurodegeneration and 
coronavirus-induced acute encephalitis, regulatory T cells have a protective effect against 
superfluous inflammation and cell-mediated cytotoxicity (Anghelina et al., 2009; Liu et al., 
2009).  Addressing these questions may explain the observation of Planz, et al that “The 
characteristics [of some helper T cells] suggest the presence of an intermediate or unusual 
phenotype of T-helper cells.” (Planz et al., 1995).      
7.  Proventricular Dilatation Disease 
Proventricular Dilatation Disease (PDD) is a fatal disease of mainly psittacid birds that is of 
great concern to aviculturalists.  PDD was first described in the 1970‟s in a group of birds 
brought to the United States from Peru (Tizard, personal communication). Also termed macaw 
wasting disease, neuropathic gastric dilatation, and lymphoplasmacytic ganglioneuritis, PDD 
classically results in malabsorption of nutrients by its host evidenced by weight loss, diarrhea, 
and undigested food present in the feces.  PDD is highly suspect when in addition to these 
clinical signs, there are neurological symptoms such as ataxia, abnormal head movements, and 
paralysis (Gregory, 1994).  Further confirmation of PDD is determined by radiographical 
evidence of dilatation of the proventriculus (Dennison et al., 2009; Dennison et al., 2008; 
Gregory et al., 1996). Histopathologic examination reveals peripheral neuritis of the autonomic 
nerves and ganglia connected to the digestive tract.  In a PDD affected bird, the nerves and 
tissues connected to the digestive tract contain lymphoplasmacytic infiltrates consisting of 
lymphocytes, plasma cells, macrophages, and heterophils (Berhane et al., 2001).  Chickens that 
experience a similar disease resulting in proventriculitis experience a massive infiltration of T 
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cells, with CD8 T cells outnumbering CD4 T cells in the proventricular glands of infected 
chickens (Pantin-Jackwood et al., 2004).  Lymphoplasmacytic infiltrates are also found in central 
and peripheral nervous tissue of PDD infected birds that include the brain and spinal cord in the 
form of perivascular cuffing.  In addition to the nervous and digestive systems, 
lymphoplasmacytic infiltrates have been described in the myenteric plexuses and connective 
tissue of the heart, adrenal glands, and other tissues in varying severity in birds diagnosed with 
PDD (Perpinan et al., 2007; Vice, 1992). These non-suppurative inflammatory infiltrates, 
especially in the crop, are the hallmark histopathologic diagnosis of PDD.  A viral agent has long 
been suspect as the cause of this disease.  Viruses thus far implicated include adenovirus, avian 
encephalitis virus, avian herpesvirus, coronavirus, eastern equine encephalitis virus, enterovirus, 
paramyxovirus, and polyomavirus, among others (Gough et al., 2006; Gough et al., 1996; 
Gregory, 1995, 1997a, b; Grund, 1999; Grund et al., 2002)       
Accurate diagnosis of PDD has presented a challenge for avian medicine practitioners 
and researchers.  Crop biopsy has been the standard method for PDD diagnosis with reported 
success rates of about 60 to 70% (Gregory et al., 1996). However, a significant number of PDD 
cases have been presented as not having any lymphoplasmacytic infiltrates in the crop (Doolen, 
1994a).  In another study, different sections of crops from birds histologically diagnosed with 
PDD were examined to determine if there was any tendency for lymphoplamacytic infiltration to 
accumulate in a specific section.  The investigators concluded there was no correlation between 
location of crop biopsy and improved accuracy of PDD diagnosis (Gregory et al., 1996). Other 
methods for PDD diagnosis include radiography of the proventriculus to check for enlargement.  
However, proventricular dilatation may also be caused by metabolic and gastrointestinal 
problems due to proventricular stasis.  General gastrointestinal stasis may be caused by lead 
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toxicosis, internal papillomas, proventriculitis, tumors and various metabolic disorders (Bond et 
al., 1993).  In addition, the orientation of the proventriculus relative to the ventriculus varies 
between psittacine species, thus making it more difficult to determine proventricular distention.  
Likewise, certain species of parrots have a naturally distended proventriculus making diagnosis 
of PDD in juvenile birds more complicated (Hoppes, personal communication). These 
complications make radiographs often unreliable for PDD diagnosis. Serological diagnosis of 
PDD is an alternative option.  Because virus isolation and identification has until recently been 
largely unsuccessful, PCR and ELISA techniques have not been employed in diagnosing PDD.  
Grund and colleagues proposed that paramyxovirus infection is associated with PDD and 
therefore may serve as a diagnostic test (Grund et al., 1999).  This theory was put to practice.  A 
population of 50 Spix‟s macaws, one out of three left in the world, at Al Whabra suffered an 
outbreak of PDD in 2004.  Since that time, screening for PDD by both crop biopsy and detection 
of antibodies to avian paramyxovirus (APMV) was implemented.  In 2008, Deb and colleagues 
presented results that suggested crop biopsies were only 30% sensitive for diagnosing PDD that 
was later confirmed by histopathology.  Furthermore, APMV-1 seropositivity was only 22.3% 
sensitive in diagnosing cases of PDD that were later confirmed by crop biopsy (Deb et al., 2008).  
In their opinion, Deb and colleagues found that antibodies to avian paramyxovirus were less 
accurate than crop biopsy for diagnosis of PDD. 
 The summer of 2008 ushered in significant advances in PDD research.  One group of 
researchers from the University of California, San Francisco, used a pan-viral microarray to 
detect BV hybridization in 5 of 8 PDD cases and none in 8 PDD negative cases, all verified by 
histopathology.  Using ultra high throughput sequencing, the group partially sequenced 16 BV 
isolates and characterized 5 different strains of the virus.  The group dubbed this virus Avian 
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Borna Virus (ABV) since this newly described virus shared around 64% nucleic acid homology 
with mammalian BV (Kistler et al., 2008).  A group at the Schubot Center for Exotic Bird Health 
at Texas A&M University, College of Veterinary Medicine published the discovery of a 38 kDa 
antigen in the brains of 5 of 5 PDD cases and none in 3 PDD negative cases, all confirmed by 
histopathology.  This research involved the use of a western blot technique with brain 
homogenate of PDD infected and uninfected birds as the antigen source and serum from the 
same birds to determine the presence of the 38 kDa antigen (Villanueva et al., 2008).  A third 
group from Columbia University was the first to publish the DNA primer sequences to detect a 
newly discovered BV in parrots infected with PDD.   This group subsequently published their 
findings in which this newly described BV was detected in 3 PDD positive birds and none in 4 
PDD negative birds, all confirmed by histopathology.  Honkavuori and colleagues also 
determined that antibodies against mammalian BV N and P proteins were not reactive with 
antigen from PDD infected bird tissue homogenates (Honkavuori et al., 2008).  The lack of 
reactivity between mammalian BV proteins and avian antibodies from birds infected with PDD 
was observed at the Schubot Center at Texas A&M in a collaborative effort with Honkavuori and 
colleagues at Columbia University.  These findings reiterated the lack of antigenic cross 
reactivity between avian and mammalian Borna viruses (Villanueva et al., unpublished 
observations). Researchers also determined that ABV was capable of infecting both neuronal and 
non-neuronal tissue, was able to grow in chicken and quail cell lines, and antibody against 
mammalian P protein was cross reactive with P protein from a genotype 2 virus (Rinder et al., 
2009).  That a new pathogen had been discovered was not debatable.  However, if ABV was the 
etiological agent of PDD was not proven until a year later.  Cockatiels that were determined to be 
PDD negative by PCR detection of ABV in fecal samples were inoculated orally with brain 
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homogenate from a PDD infected bird, or from a PDD negative bird.  Cockatiels infected with 
PDD homogenate succumbed to disease that clinically and histopathologically resembled PDD.  
Though the brain homogenates contained 2 other viruses, it was not shown that these viruses 
caused infection; control birds remained normal (Gancz et al., 2009).  ABV infection studies 
with similar results were carried out at the Schubot Center.  Patagonian conures succumbed to 
PDD following inoculation with ABV infected cell culture while a conure inoculated with ABV 
negative cell culture remained healthy (Gray, 2009).  ABV tropism in the central nervous system 
was further elucidated by histopathology and immunohistochemistry performed in PDD infected 
birds and PDD negative birds.  These studies showed that ABV infected primarily neurons, and 
glial cells. ABV had a detrimental effect on the Purkinje cell layer of the cerebellum.  Cell 
atrophy in the Purkinje cell layer was curious in that it was thought to be caused by cell death of 
surrounding subpopulations of neighboring cells (Ouyang et al., 2009).  
 The following chapters describe the development of a serodiagnostic test for PDD and 
the implementation of such a test to determine its diagnostic value as a bona fide test for PDD.  
The main antigen of this test is then purified, revealing some interesting characteristics about the 
AVB nucleoprotein as an immunogen. 
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CHAPTER II 
DETECTION OF AN ANTIGEN SPECIFIC FOR PROVENTRICULAR DILATATION 
DISEASE IN PSITTACINE BIRDS 
 
1.  Introduction 
 
 Proventricular dilatation disease (PDD) is an often fatal disease of psittacine birds and 
perhaps wild birds (Daoust et al., 1991; Gregory, 1997b; Perpinan et al., 2007; Weissenbock et 
al., 2009b).  PDD has been documented in South American, African, and Australian parrots, 
suggesting that this disease may have world-wide distribution (Clark, 1984; Doneley et al., 
2007).  The cases documented have mainly been on parrots in the pet trade, but it is entirely 
plausible that wild parrots may harbor the disease as well.  The classical presenting sign is 
paralysis and dilatation of the proventriculus secondary to nerve damage in the affected organs.   
Birds afflicted with PDD will classically present undigested seeds in their feces, regurgitation, 
lethargy, and ataxia and even blindness (Steinmetz et al., 2008).  Some birds may present only 
gastrointestinal symptoms whereas others will present mainly neurological symptoms.  
Oftentimes, birds with PDD will display both types of clinical symptoms, attesting to the 
complex nature of the disease and its pathogenesis.  Grund and others (2002) have suggested that 
PDD is caused by a paramyxovirus, whereas Gough and colleagues (2006) have suggested the 
disease is associated with a coronavirus.  Though a virus like particle has been observed in the 
feces of a bird with PDD, the disease has only reportedly been duplicated after brain homogenate 
from a PDD infected bird was fed to other parrots (Gough et al., 1996).  Unfortunately, evidence 
of these and other viruses in birds affected with PDD has been erratic and inconsistent.  
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Diagnosis of the disease is therefore largely based on clinical signs supplemented by histological 
examination of the crop tissue. Lymphocytic infiltration of the ganglia of the crop occurs in 
about 60 to 70 per cent of PDD cases (Doolen, 1994b).  
 One consistent feature of PDD affected birds is the presence of lymphoplasmocytic 
encephalitis in the form of perivascular cuffing on postmortem examination.  Because large 
numbers of plasma cells in these perivascular cuffs implies a robust antibody response by the 
host, studies were initiated to determine which antigens were being targeted by these plasma 
cells.  We therefore homogenized brain tissue samples from parrots that were euthanized.  
Serum, or plasma, was also submitted along with the bird‟s tissue samples in order to test the 
bird‟s serum against its own tissues and with tissues of birds known to be PDD positive or 
negative by postmortem examination.  
2.  Materials and Methods 
  
2.1  Sample materials 
 
 One scarlet macaw (Ara macao), one yellow-collared macaw (Primolius auricollis), two 
blue-and-gold macaws (Ara ararauna), and one African grey parrot (Psittacus erithacus) were 
all diagnosed as being affected with PDD by a board certified avian pathologist at the Texas 
Veterinary Medical Diagnostic Laboratory at Texas A&M University.  Tissues obtained during 
the necropsy were placed in 1.7 ml microcentrifuge tubes on ice for temporary storage and then 
at -80° C until further use.  Blood samples were obtained by clinicians and interns at the Texas 
A&M College of Veterinary Medicine, Small Animal Hospital, Exotic Zoo Ward in red top tubes 
and allowed to clot.  The blood was then spun down in a microcentrifuge for 6000g for 10 
minutes at 4°C.  Serum was stored at -80°C until further use. 
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2.2  Antigen preparation 
 Tissue samples were thawed and a small piece was cut then weighed.  The sample was 
then put into a glass grinder and a 1:10 g/ml suspension was made with PBS (Sigma, St. Louis, 
MO, USA) pH 7.4.  All samples were kept on ice until aliquoted and stored at -80°C.   
Homogenized tissue samples were centrifuged at 200g for 5 minutes at 4°C to remove large 
debris from solution.  
2.3  SDS-PAGE and protein stain 
 Homogenized tissue samples were loaded onto 10% Tris-HCl polyacrylamide minigels 
prepared in Tizard/Ni lab according to the lab manual.  Tissue samples to be tested were 
prepared by adding 12 µL of  reducing, denaturing sample buffer (BioRad, Hercules, CA, USA), 
prepared according to manufacturer‟s instructions, along with 12 µL of homogenized tissue 
extract in a 1.7 mL microcentrifuge tube.  The samples were boiled in water for 5 minutes and 20 
µL of each tissue sample was added to each well of the SDS gel. A pre-stained broad range 
molecular weight ladder (BioRad, Hercules, CA, USA) was used to estimate the molecular 
weight of reactive proteins.  SDS gels were run for 40 minutes at 80 amps, or 40 amps for one 
gel.  SDS gels were stained for protein by incubation with Coomassie stain for 20 minutes on a 
shaker.  Gels were de-stained by incubation in 7% acetic acid, 10% methanol in ultrapure water 
overnight then stored in ultrapure water.  Gels were also silver stained (Pierce, Rockford, IL, 
USA) to visualize smaller quantities of protein.    
2.4  Western blot 
Western blots were performed based on methods originally described elsewhere (Towbin 
et al., 1979).  Tissue extracts were electrophoresed on 10% polyacrylamide gels. Proteins were 
transferred to a polyvinylidene fluoride (PVDF) in transfer buffer at 100 mA for 2 hours. 
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Membranes were blocked with PBS (Sigma, St. Louis, Missouri USA) pH 7.4 plus 3% non-fat 
dry milk and 0.05% Tween 20 shaking at room temperature for 2 h.  Test sera were diluted 1:100 
in PBS plus 1.5% BSA and 0.05% Tween 20 and exposed to the antigen blots at room 
temperature for 2 h. Membranes were rinsed 3 times for 5 min with PBS plus 0.05% Tween 20. 
Membranes were then incubated with alkaline phosphatase labeled goat anti-macaw IgY (Bethyl 
Laboratories, Montgomery, TX) at a dilution of 1:10,000.  The membrane was rinsed again and 
developed for 10 minutes with 5-bromo-4-chloro-3-indolyl phosphate/p-nitroblue tetrazolium 
chloride (BCIP/NBT) from Sigma. Membranes were rinsed briefly with ultrapure water and air 
dried for about 30 minutes before determining final results. 
3.  Results 
3.1  Identification of 38 kDa antigen 
 Tissue samples collected from necropsied birds were thawed and homogenized.  Nervous 
tissue was very fatty and therefore hard to homogenize with PBS alone at room temperature.  At 
the other extreme were the proventriculus and ventriculus which consist of tough muscle and 
were also hard to homogenize.  Given the scarcity of the tissue samples obtained, and the 
different composition of lipid and protein of the different tissue samples, protein concentration 
assays were not originally performed.  On some birds, not all tissues desired were obtained due 
to elapsed time since death which causes parts of the brain and spinal cord to autolyse.  The 
adrenal glands were not positively identified on some birds because of elapsed time from death 
to necropsy.  Coomassie stains suggested protein samples contained roughly the same amount of 
protein.  SDS-PAGE and Coomassie stains were originally performed with dilutions of tissue 
homogenates at 1:10, 1:100, and 1:1000.  Western blots were performed with a serum dilution of 
1:100 and reacted very strongly with numerous proteins at all homogenate dilutions.  It was 
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found that serum diluted 1:5000 was still able to clearly detect PDD antigen in the western blot.    
When compared to western blots performed with tissue homogenates from birds that were 
diagnosed as PDD negative post-mortem, the dominant antigen that came to be associated with 
PDD was a 38 kDa protein.  Other antigens that were reactive with serum from a PDD bird were 
presumably antigens associated with chronic encephalitis, autoantigens, or other viral antigens.   
3.2  Standardization of western blot 
 Based on preliminary results, a standard western blot protocol was established in an 
attempt to validate the correlation of PDD with the newly discovered 38 kDa antigen.  Serum 
samples of birds to be tested were diluted at 1:100, unless otherwise noted.  Positive control 
western blots were performed with known PDD positive sera at 1:5000.  In fact, some sera 
reacted just as intensely with the 38 kDa antigen at a dilution of 1:5000 as they did at a 1:100 
dilution.  Antigen source for western blots were brain or heart tissue homogenate from PDD 
positive and PDD negative birds, diluted 1:50 w/v in PBS.  Some western blots were performed 
with tissue homogenates from multiple organs to determine PDD tropism.  Western blots 
revealed that tissues of all PDD-affected birds contained an antigen of approximately 38 kDa that 
was recognized by positive bird serum.  The antigen was present in the forebrain, midbrain, 
hindbrain, spinal cord, sciatic nerve, and in small quantities in the adrenal gland of some birds.  
In the yellow-collared macaw, the PDD antigen was additionally present in the heart and vagus 
nerve.  Surprisingly, the antigen was not detected in the gastrointestinal tract including the crop, 
proventriculus, ventriculus, small intestine (Fig. 1).  The antigen was also not detected in the 
feces, blood, liver, or kidney of PDD affected birds. A western blot performed with only the 
secondary antibody showed it was reactive with light and heavy chains of IgY present in the 
tissue homogenates (Fig. 2).  The 38 kDa antigen was absent from the tissues of a scarlet macaw  
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                  A    B        C      D        E      F      G     H       I        J      K 
               
Figure 1. Western blot of infected macaw.  Western blot of tissues from a scarlet macaw with 
proventricular dilatation disease confirmed at postmortem examination.  Serum from the same 
bird was used as the primary antibody.  A, molecular weight ladder; B, Adrenal gland; C, 
Forebrain; D, brainstem; E, Cervical spinal cord; F, Thoracic spinal cord; G, Sacral spinal cord; 
H, Ventriculus; I, Proventriculus; J, Intestinal contents; K, Cloacal swab. The positive band at 
approximately 50 kDa reflects the presence of immunoglobulin heavy chains and the band at 
approximately 25 kDa reflects the presence of light chains. 
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               A    B     C      D     E      F      G     H     I    J      K     L     M 
              
 
Figure 2. Western blot of infected macaw, secondary antibody control.  Western blot of tissues 
from a scarlet macaw with proventricular dilatation disease confirmed at postmortem 
examination.  Serum from the same bird was used as the primary antibody.  A, molecular weight 
ladder; B, Adrenal gland; C, Forebrain; D, brainstem; E, Cervical spinal cord; F, Sacral spinal 
cord; G, Thoracic spinal cord; H, Crop; I, Ventriculus; J, Intestinal contents; K, Cloacal swab; L, 
Heart; M, Proventriculus. The positive band at approximately 50 kDa reflects the presence of 
immunoglobulin heavy chains and the band at approximately 25 kDa reflects the presence of 
light chains. 
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and two blue-and-gold macaws that were euthanized for chronic health problems unrelated to 
PDD.  
3.3  Seroprevalence of antigen in live birds 
 We next sought to test serum from birds held at the Schubot aviary for the presence of 
antibodies to the 38 kDa antigen.  Sixteen birds of varying species, mostly macaw, were 
determined to be PDD positive based on crop biopsy and/or a history of clinical symptoms found 
to be associated with PDD.  Of the 16 birds, 12 were found to have antibodies to the 38 kDa 
protein.  A population of 15 birds, deemed to be PDD negative by the same criteria, was tested 
for the presence of the 38 kDa protein.  Two out of the 15 sera gave weak positive reactions.  
3.4  Presence of antibodies to other pathogens 
 In an attempt to determine the nature of the antigen detected by the western blot, a search 
was undertaken to find antigens of known pathogens that cause a similar disease in their hosts.  
A leading candidate was the VP1 protein of Theiler‟s murine encephalitis virus, a picornavirus, 
with a molecular weight of approximately 33-35 kDa (Lipton and Friedmann, 1980).  In 
collaboration with Dr. Jane Welsh‟s lab at Texas A&M University, ELISAs were performed by 
Dr. Andrew Steelman demonstrating that serum from PDD infected birds, as well as some PDD 
negative birds, contained antibodies against strains of Theiler‟s murine encephalitis virus 
(TMEV) BeAn and GDVII strains.  However, an ELISA with influenza virus A/Singapore/97 
H5N3 hemagglutinin protein presented results similar to the ones obtained with TMEV.  
Flaviviruses are known to cause encephalitis in susceptible hosts, but have thus far not been 
associated with PDD.  The question was posed as to whether we were detecting an antigen from 
a previously uncharacterized flavivirus.  Western blots were carried out in which serum from 
West Nile virus positive raptors was exposed to PDD brain homogenate.  Results from these 
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western blots showed that West Nile antibodies were not cross reactive with antigens from the 
PDD agent.  However, it was not ruled out that raptors may also be affected with PDD.  Finally, 
it has been reported that avian paramyxovirus-1 may be associated with PDD.   Therefore, a 
hemagglutination inhibition assay was performed in Dr. Sanjay Reddy‟s lab by Dr. Pam Farrow 
to determine if PDD positive serum was cross-reactive with avian paramyxovirus-1 antigen.  A 
hemagglutination inhibition assay was performed according to a protocol established by 
TVMDL.  Results, including PDD negative serum, indicated that none of the birds were making 
antibodies against avian paramyxovirus-1 HN protein. 
4.  Discussion 
 PDD is of serious concern to aviculturalists and bird owners alike.  This disease was first 
described in the 1970‟s and has been recorded in over 50 species of parrots as well as non-
psittacine birds (Clark, 1984; Daoust et al., 1991; Weissenbock et al., 2009b).  PDD is mostly 
described as a non-suppurative encephalomyelitis in conjuction with peripheral ganglioneuritis 
of the gastrointestinal tract upon post-mortem examination. This disease is fatal and has been 
studied for about 30 years. Despite decades of research, many important questions remain as to 
the etiological agent, mode of transmission, diagnosis, and treatment of this disease.  Currently, 
diagnosis of PDD in live birds is done by crop biopsy, which is about 40-60% accurate, and by 
radiographs of the digestive system (Dennison et al., 2009; Doolen, 1994b).  Serological testing 
as a means of identifying novel pathogens does not have much precedence given the advent of 
pan-viral microarrays and high throughput pyrosequencing as the preferred methods of pathogen 
identification.  These methods not only require expertise from personnel, but may be expensive if 
a lab is not equipped to run such experiments.  Our approach was to exploit the antigenic 
specificity of the humoral immune response in order to identify its target antigen. An abundance 
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of lymphoplasmacytic infiltrates are found in the brains of birds diagnosed with PDD in the form 
of perivascular cuffing.  Therefore, experiments were devised to find an antigen associated with 
the birds diagnosed with PDD but absent from non-PDD birds.     
One such antigen was readily detected by serum from PDD infected birds against 
proteins found in their own brain homogenates.  Most importantly, no antigen or antibodies 
against the 38 kDa antigen was found in PDD negative birds.  While the nature of this antigen 
remains unclear, it is suspected to be of viral origin or perhaps a neurotoxin.  It is also possible 
that this may be a virally produced toxin.  The serum of affected birds does not react 
significantly with any antigens in normal macaw brains; therefore, it is unlikely to be an 
autoantigen.  The antigen is found at all levels in the spinal cord and in the fore-, mid-, and 
hindbrain.  Its absence from Western blots of affected gastrointestinal tract may simply reflect 
the relative paucity of nervous tissue within these organs.  It‟s presence in one of five hearts 
suggests that the heart sample taken may possibly have included some nerve tissue, although 
heart lesions were present in this bird on histopathological examination and have been associated 
with PDD (Perpinan et al., 2007; Vice, 1992).  The antigen was not detected in any tissue from 
the three apparently PDD negative birds tested. 
The presence of antibodies to this protein in 12 of 16 PDD-confirmed parrots and their 
absence in apparently normal birds may provide a basis for a serodiagnostic test for this disease.  
It is important to note that the sera were found to be reactive with the antigen at a dilution of 
1:5000.  Less diluted samples may result in a higher seroprevalence.  There were four birds with 
negative serology that were crop biopsy positive.  In testing 15 birds believed to be negative for 
PDD, two serum samples gave weak positive reactions.  Given the insidious nature of PDD, it is 
not surprising that otherwise healthy birds may in fact be positive for the disease.  Nevertheless, 
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two possibly false positives out of 15, and four false negatives out of 16 suggest that detection of 
antibodies to this antigen by Western blotting or by other serological methods may be useful in 
confirming the diagnosis of PDD. 
The presence of antibodies to other viruses was not surprising.  The birds tested are all 
housed in an outdoor aviary and some have been adopted from previous owners.  Parrots housed 
in outdoor aviaries are exposed to the same pathogens that may be carried by rodents and wild 
birds.  Parrots that are housed indoors and therefore have more intimate contact with their 
owners are also exposed to pathogens carried by their owners, and vice versa.  Therefore, it is 
entirely expected that these birds are exposed to viruses such as influenza, which can be carried 
by humans and birds as well as many mammals.  It was surprising that these birds had antibodies 
to TMEV since this virus is not thought of as an avian pathogen.  It seemed plausible that these 
birds had come into contact with wild mice that were carriers of TMEV, since TMEV in wild 
mice has been observed (Moro et al., 2003).  However, there was no correlation between anti-
TMEV antibodies and PDD status.  Serum from birds with high titers of antibodies against 
WNV, a virus known to cause avian encephalitis, was not found to be reactive with the 38 kDa 
antigen.  Though this does not imply that these birds have not been exposed to WNV, it does 
show that this antigen is immunologically different from WNV.  Antibodies against one type of 
flavivirus E protein, the major antigenic envelope protein, are broadly cross reactive against 
other members of the flaviviradae family (Stiasny et al., 2006).  Therefore, it is likely that the 38 
kDa antigen is not from a flavivirus. Avian Paramyxovirus-1 has been implicated as a possible 
cause of PDD (Grund, 1999; Grund et al., 2002).  We found that none of our birds produced 
detectable antibodies against AMPV-1 HN protein.   
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 By use of Western blotting, a dominant antigen was detected in the brains of birds 
affected with PDD by use of the bird‟s own serum.  This serological test could be developed and 
standardized as perhaps a supplement to crop biopsy for PDD diagnosis.  In these studies, 
assuming that all birds believed to be PDD positive were in fact positive, then the serological test 
has an accuracy of 75%.  This represents an improvement in PDD diagnostic accuracy by 5 to 
15%, but a larger sample size will have to be tested in order to verify if there is an improvement.  
This PDD antigen is most likely not from a flavivirus, or the long-suspected APMV-1.  Thus far, 
the specificity of the test for the PDD antigen appears to be 86.6%.  Immediately, this antigen 
will need to be isolated and characterized in hopes of identifying the pathogen that may be 
responsible for PDD.  More studies will have to be undertaken to determine the value of the 
Western blot as a diagnostic test for PDD.    
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CHAPTER III 
PURIFICATION AND IDENTIFICATION OF A 38 KDA ANTIGEN ASSOCIATED WITH 
PDD 
 
1.  Introduction 
 Proventricular dilatation disease (PDD) is a fatal neurologic disease of mainly psittacine 
birds that has been described since the 1970‟s (Gerlach, 1991)Birds suspected of having PDD 
will exhibit neurologic signs that include ataxia, abnormal head movements, and depression.  
Neurologic signs are often seen in conjunction with gastrointestinal signs such as crop stasis, 
regurgitation and passage of undigested seeds in the feces (Gregory, 1994, 1997b; Mannl et al., 
1987).  Historically, only postmortem diagnosis has been considered definitive for PDD.  
Histopathology of diseased birds reveals an infiltration of T cells, plasma cells and macrophages 
in the myenteric plexus of the proventriculus and the ventriculus.  In addition to gastrointestinal 
pathology, there is an abundance of nonpurulent inflammatory lesions in the brain, spinal cord 
and autonomic nerves (Berhane et al., 2001; Lublin, 2006; Mannl et al., 1987).  Many viruses 
including Eastern equine encephalitis virus, coronavirus, and avian paramyxovirus 1 have been 
proposed as the possible etiologic agent of PDD, but proof has not been established (Gough et 
al., 2006; Gregory, 1997a; Grund et al., 2002).  The only way that PDD was able to be replicated 
in birds was by exposure to tissue homogenate from birds that were diagnosed with PDD 
(Gregory, 1998).     
Avian Borna Virus (ABV), a newly discovered member of the family of the 
bornaviridae, has recently been implicated as a possible etiologic agent in PDD(Kistler, et al, 
2008, Honkavouri et al, 2008).  Like it‟s mammalian counterpart, ABV is a single-stranded 
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negative sense RNA virus that codes for 6 proteins including L, G, N, P, X, and M.  ABV is 
sequentially divergent from mammalian Borna virus (BV) with less than 70% nucleotide 
homology to Borna virus, possibly representing a new virus (Honkavuori et al., 2008; Kistler et 
al., 2008).  Under these auspices, it may be assumed that ABV proteins might behave in a 
different biological and perhaps pathological manner to that of BV viral proteins.  Unlike BV in 
a mammalian host, ABV in an avian host seems to have the added effect of a wasting disease in 
addition to a neurological component of the disease.  Cockatiels naturally infected with ABV 
genotype 4 were clinically normal until superinfection with ABV genotype 4 induced disease.  
Though too early to tell, this may imply higher pathogenicity of certain strains over others 
(Tizard, 2009a).  Additionally, ABV is consistently found in extraneuronal tissues of infected 
birds (Gancz et al., 2009; Honkavuori et al., 2008; Lierz et al., 2009; Rinder et al., 2009; 
Weissenbock et al., 2009a).      
Nucleoprotein (N) and the phosphoprotein (P) are the major immunogenic proteins of 
Borna virus (Schwemmle et al., 1998).  The humoral immune response of the BV infected host is 
mounted against either the N, P, or both proteins.  It is thought that birds infected with ABV may 
mount a similar humoral immune response (Villanueva, et al, 2009, unpublished observations). 
The N protein of 7 ABV isolates share anywhere between 70% to 100% sequence homology at 
the nucleotide level amongst each other (Weissenbock et al., 2009a).  The ABV nucleoprotein is 
also significantly different from the BV nucleoprotein (Honkavuori et al., 2008; Kistler et al., 
2008).  The N protein exists as two isoforms at 38 kDa and 40 kDa, due to alternative translation 
initiation sites in the viral genome (Kobayashi et al., 1998).   Though both isoforms of N contain 
an internal nuclear export signal, N40 kDa contains an extra 13 amino acid sequence in the N-
terminal region that codes for a nuclear localization sequence (Kobayashi et al., 2001; Kobayashi 
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et al., 1998). Both avian and mammalian nucleoprotein is located in the nucleus and cytoplasm 
of the infected cell (Ouyang et al., 2009). Mammalian Borna virus N protein has been purified in 
part by salting out with ammonium chloride, so this method was employed first (Bause-Niedrig 
et al., 1992).  Several attempts at purifying ABV N in this manner were unsuccessful and so a 
modified or alternative method had to be established.        
Throughout the years, many methods have been used to purify proteins.   Researchers 
have taken advantage of proteins‟ specific biological and physicochemical properties in order to 
devise purification techniques.  Chromatography describes a method used to separate complex 
mixtures with a stationary phase and a mobile phase that flows through the stationary phase.  For 
the purification of ABV nucleoprotein, the protein purification method used was hydrophobic 
interaction chromatography (HIC) due to the unusually hydrophobic nature the protein seemed to 
exhibit.  HIC has been widely used as a powerful tool for protein separation and purification in 
industry and research (Lu et al., 2009).  This method of chromatography separates proteins based 
on their hydrophobic properties with varying affinity through electrostatic and van der Waals 
forces.  A hydrophobicity column was ideal for the separation of the N protein not only due to its 
hydrophobicity, but also because the protein was only present in small amounts of homogenized 
tissue preparations according to Coomassie and silver stains.  Thus, the HIC column would serve 
to concentrate the N protein.  SDS-PAGE and immunoaffinity were used in conjunction with 
HIC in order to effectively purify the ABV nucleoprotein.  Identification of the purified protein 
was undertaken with MS/MS mass spectroscopy after in gel digestion of the protein. 
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2.  Materials and Methods 
2.1  Antigen sources 
  A female eclectus parrot (Eclectus roratus) was euthanized for humane reasons as a 
result of PDD. The bird tested seropositive for ABV (case number 09-096) based on western 
blotting with duck embryo fibroblasts as the antigen source. Aqueous and vitreous fluids were 
collected together out of the left eye with a 21 gauge syringe during necropsy. The fluids were 
dispensed into a microcentrifuge tube and kept in ice until the necropsy was finished.  The 
sample was then kept at 4ºC for 48 hours until a western blot could be performed to determine if 
ABV was present in the eye.  Previous attempts to purify the ABV nucleoprotein used different 
antigen sources.  Homogenized heart tissue from a PDD positive yellow collared macaw 
(Primolius auricollis), confirmed by histopathology, was used at a 1:50 w/v tissue in PBS (pH 
7.4) as described before (Villanueva, et al 2008).  Another source for purification of ABV 
nucleoprotein was obtained from duck embryo fibroblasts (DEF) infected with ABV according 
to the method of Dr Patricia Gray and Dr Paulette Suchodolski.  The infected DEFs were shown 
to contain ABV nucleoprotein by western blot.  
2.2  2-D gel electrophoresis 
Two-dimensional gel electrophoresis was performed by Dr. Larry Dangot at the Protein 
Chemistry laboratory at Texas A&M University.  Briefly, isoelectric focusing of protein sample 
was performed overnight at room temperature on an Amersham Pharmacia Biotic IPTGPhor 
electrophoresis module using an immobilized pH gradient on a polyacrylamide strip.  The second 
dimension is run on a vertical slab gel electrophoresis unit.  In experiments where a western blot 
was to be performed, Dr. Dangot‟s laboratory also performed electrophoretic transfer of the 
protein gel onto PVDF membranes according to their laboratory‟s protocol (www.pcltamu.com).  
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It is worth mentioning that the PCL protocol is similar to our electrophoretic protocol, except 
that the transfer buffer used by their laboratory uses CAPS (3-[cyclohexylamino]-1-propane-
sulfonic acid, Sigma, St. Louis, MO USA) buffer (10mM CAPS plus 10% methanol, pH 11.0) 
whereas our protocol uses Tris-HCl, Glycine, 10% methanol,    
2.3  Purification with magnetic beads 
 Dynabeads® M-280 Tosylactivated magnetic beads used to purify antigen were used 
according to manufacturer‟s instructions (Carlsbad, CA USA).  Briefly, beads were sufficiently 
washed according to manufacturer‟s instructions, except that no BSA was used in any of the 
solutions.  Seventy microliters of IgY, precipitated by ammonium sulfate, was diluted in 230 µL 
of PBS from a PDD infected bird (M24, yellow collared macaw) was incubated with 60 µL of 
magnetic beads overnight at room temperature. Beads were then washed 3 times with PBS plus 
0.05% Tween 20 to wash beads of unbound protein from serum.  Various elution methods were 
attempted in order to desorb the antigen from the antibody.  One such method was the addition 
100 µL of 100 mM glycine, pH 2 followed by immediate addition of 300 µL of 1mM Tris-HCl 
to unbound antigen.  Addition of different detergents to desorb antigen was also attempted.          
2.4  Hydrophobic interaction chromatography 
A method originally suggested by Dr. Paul Stroud was modified and used to isolate the 
ABV nucleoprotein.  This method may also be described as reversed-phased chromatography.  
Briefly, 50 µl of eye fluid was diluted in 150 µl of PBS.  This sample was then pipetted into a 
200 µl Phenyl-Sepharose® 6 Fast Flow (Sigma, St. Louis, MO USA) column that had been 
adequately rinsed with PBS.  The column was then rinsed with 400 µl 0.5% Tween 20 followed 
by a rinse with 400 µl PBS to elute proteins that were not of interest off of the column.  The 
column was then rinsed with 200 methanol (Fisher Scientific, Fair Lawn, NJ USA) followed by 
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200 µl of PBS as a final rinse.  All eluates were collected in microcentrifuge tubes and 
immediately stored at 4ºC.  Samples were loaded onto an SDS gel shortly thereafter on the same 
day for a western blot and Coomassie stain.  The column was then thoroughly rinsed with PBS 
and then stored in PBS plus 0.01% sodium azide until further use.    
2.5  SDS-PAGE  
 Protein samples were loaded onto 10% Tris-HCl polyacrylamide minigels prepared in 
Tizard/Ni lab according to standard lab protocols.  Protein samples for electrophoresis were 
prepared by adding 12 µL of reducing, denaturing sample buffer (BioRad, Hercules, CA, USA), 
prepared according to manufacturer‟s instructions, along with 12 µL of protein sample in a 1.7 
mL microcentrifuge tube.  The samples were boiled in water for 5 minutes and 20 µL of each 
tissue sample was added to each well of the SDS gel. A pre-stained broad range molecular 
weight ladder (BioRad, Hercules, CA, USA) was used to estimate the molecular weight of 
reactive proteins.  SDS gels were run for 40 minutes at 80 amps, or 40 amps for one gel.  SDS 
gels were stained for protein by incubation with Coomassie stain for 20 minutes on a shaker.  
Gels were de-stained by incubation in 7% acetic acid, 10% methanol in ultrapure water overnight 
then stored in ultrapure water.  Gels were also silver stained (Pierce, Rockford, IL, USA) to 
visualize smaller quantities of protein.    
2.6  Western blot  
Western blots were performed based on methods originally described by Towbin, et al. 
(Towbin et al., 1979). Proteins were transferred to a polyvinylidene fluoride (PVDF) in transfer 
buffer at 100 mA for 2 hours. Membranes were blocked with PBS (Sigma, St. Louis, Missouri 
USA) pH 7.4 plus 3% non-fat dry milk and 0.05% Tween 20 shaking at room temperature for 2h.  
Test sera were diluted 1:100 in PBS plus 1.5% BSA and 0.05% Tween 20 and exposed to the 
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antigen blots at room temperature for 2 h. Membranes were rinsed 3 times for 5 min with PBS 
plus 0.05% Tween 20. Membranes were then incubated with alkaline phosphatase labeled goat 
anti-macaw IgY (Bethyl Laboratories, Montgomery, TX) at a dilution of 1:10,000.  The 
membrane was rinsed again and developed for 10 minutes with 5-bromo-4-chloro-3-indolyl 
phosphate/p-nitroblue tetrazolium chloride (BCIP/NBT) from Sigma. Membranes were air dried 
for about 30 minutes before reading.  Positive control serum was obtained from M24, a yellow-
collared macaw with clinically, necropsy- and histologically confirmed PDD. For control 
purposes, serum from M21, a blue-and-gold macaw (Ara ararauna) histopathologically 
confirmed to be free of PDD lesions, was used as a negative control. 
2.7  MS/MS analysis 
 Protein samples identified on SDS gel with Coomassie stain were stored in ultrapure 
water at 4°C until they could be submitted for identification.  Protein samples were submitted to 
Dr William Russell for MS and MS/MS analysis at the Laboratory for Biological Mass 
Spectrometry at Texas A&M University.  Protein sequences obtained were searched against 
protein databases including NCBI, Swiss Prot and the chicken genome for possible 
identification.  
3.  Results 
3.1  Antigen sources and initial descriptions 
 Four different antigen sources were used in attempts to purify the 38 kDa antigen that 
appeared on western blots.  Homogenate from the hind brain of a yellow-collared macaw was 
first used because it was in abundant supply.  Previous results had shown the antigen to be 
present in the hind brain of PDD affected birds.  Brain homogenate is very abundant in lipids and 
therefore difficult to work with because of the formation of precipitates.  Protein solutions are 
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constantly maintained on ice in order to avoid excessive protein degradation.   When brain 
homogenate was maintained in cold temperatures, large precipitates formed.  Because of this, it 
was difficult to concentrate the brain homogenate and maintain uniform solutions for testing.  
Another consequence was that such lipid heavy solutions were not conducive to downstream 
applications of protein purification.  It was soon discovered from a Western blot that the same 
yellow-collared macaw, from which the brain homogenate was generated, also contained the 38 
kDa antigen in heart homogenate.  Heart homogenate contained much less lipid and therefore 
greatly alleviated the problems associated with purification of protein from lipid rich solutions.  
However, previous results along with newly acquired results suggested conflicting conclusions.  
The western blot stained brightly, yet no protein was ever detected on the corresponding 
Coomassie, or silver stained gel (Fig. 3).  This was also the case for the PDD-infected tissue 
culture homogenate from which antigen purification was also attempted.  At a concentration of 
300 µL of infected tissue culture, there was still no visible protein band that corresponded to the 
bright band of the Western blot.  It was concluded that the antigen was present in very small 
amounts in the homogenates, but readily detected by an overwhelming antibody response.  
Additionaly, antigen from tissue culture was subjected to n-glycanase treatment at which it was 
determined that the antigen contained an n-linked glycosylation site (Fig. 4A).  In order to 
disprove the theory that the antigen may perhaps be a prion, M24 infected tissue culture was 
submitted to proteinase K treatment for 1 hr. at 37°C (Fig. 4B).  Failure of a western blot to 
detect the antigen after proteinase K treatment showed that it was most likely not a prion protein.   
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Figure 3.  Western blot and Coomassie stain of infected macaw.  Coomassie (top, A) and 
Western blot (bottom, B) of tissues from histopathology confirmed PDD negative and PDD 
positive scarlet macaws (Ara macao).  Tissues were homogenized and diluted in PBS at 1:50 
g/ml then exposed to serum diluted at 1:5000. (A) Broad range ladder, (B) Brain, (C) Brain stem, 
(D) Sacral cord, (E) Proventriculus, (F) Ventriculus, (G) Broad range ladder, (H) Brain, (I) Brain 
stem, (J) Sacral cord, (K) Proventriculus, (L) Ventriculus.  The Western blot is a replica of the 
Coomassie stain. The ABV nucleoprotein is present in PDD affected tissues and is detected by 
PDD positive serum.          
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A.                                                      B. 
 
         A   B   C   D   E                              A   B   C    D 
                                    
Figure 4.  Western blots with enzymatic treatment of antigen.  Western blots of the ABV 
nucleoprotein subjected to different types of enzymatic treatment.  A.  Brain homogenates 
subjected to treatment with n-glycanase.  (A) Broad range ladder, brain homogenate of PDD 
negative bird without (B) and with (C) n-glycanase treatment, brain homogenate of PDD positive 
bird without (D) and with (E) n-glycanase treatment.  B.  Brain homogenate subjected to 
protease K treatment.  (A) Broad range ladder, (B) brain homogenate treated with protease K at 
37°C for 1 hr., (C) brain homogenate incubated at 37°C for 1 hr., (D) untreated brain 
homogenate.  Western blots were developed with PDD positive serum diluted at 1:5000.  ABV 
nucleoprotein is indicated by the positive reactions between the 42 and 21 kDa markers on both 
blots.  
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3.2  2-D gel electrophoresis as a method of antigen purification 
 Conventional two-dimensional gel electrophoresis was performed in order to separate the 
antigen from the rest of the proteins.  PDD negative and PDD positive heart homogenates, as 
well as normal and PDD-infected DEF tissue culture cells were given to the Protein Chemistry 
Laboratory at Texas A&M for 2-D gel electrophoresis.  Western blots were negative for the 
presence of the 38 kDa antigen and the corresponding SDS gel also contained considerably less 
amount of protein than demonstrated by single-dimension SDS-PAGE.  A technique termed 
detergent swapping was attempted in order to better dissolve the proteins and better separate 
them in the isoelectric focusing step.  Briefly, the protein solution was first subjected to SDS 
treatment in order to completely separate the proteins from each other.  The SDS was then 
“swapped out” for a non-ionic detergent so that isoelectric focusing could take place.  Even after 
such attempts, it appeared that the antigen was not undergoing proper isoelectric focusing and 
was perhaps lost on the polyacrylamide strip.  An older method, in which isoelectric focusing 
was performed in a gel tubes as opposed to immobilized pH gradient strips, was also used in an 
attempt to purifiy the protein.  This technique also produced negative results and the 
whereabouts of the protein could not be accounted for.  These results indicated that the antigen 
was unable to go into solution for isoelectric focusing, perhaps due to high lipid content.    
3.3 Antigen purification using magnetic beads 
 Another approach undertaken to purify the 38 kDa antigen from tissue homogenate was 
to utilize antibody conjugated magnetic beads to bind the antigen and separate it from other 
unwanted proteins.  Antibodies in the form of whole serum were conjugated to the magnetic 
beads according to the manufacturer‟s instructions overnight at room temperature.  Protein 
dilutions were made so as to saturate the magnetic beads with protein.  To determine success of 
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antibody binding, a small amount of the magnetic beads were boiled in denaturing sample buffer 
and a western blot using only secondary anti-macaw antibody conjugated to alkaline phosphatase 
was performed to verify the presence of the heavy and light chains of macaw IgY.  Brain 
homogenate as the antigen source was first used, but quickly abandoned because of its heavy 
lipid content.  This did not allow the magnetic beads to properly incubate with the antigen 
solution at room temperature.  Tissue culture homogenate was next used as the antigen source.  
In order to further eliminate unwanted proteins, tissue culture homogenate was subjected to 
MEM-PER and NE-PER protein purification kits in order to determine if the antigen was present 
in the cellular membrane or the nucleus of infected cells, respectively.  Western blot results 
indicated that the antigen was present in both the nucleus and cytoplasm.  This finding was in 
accordance with results found in separate ongoing investigations by Gray, et al, and Ouyang, et 
al, 2009.  Therefore, whole cell tissue culture homogenate was used for subsequent experiments. 
Using the Western blot to track the presence of the protein, results indicated that the antibody 
was binding to the antibody, or perhaps the magnetic beads, and was not eluted by addition of 
glycine at pH 2, or by addition of 0.5 % Tween 20.  Addition of denaturing SDS sample buffer 
was able to elute the antigen and produce western blot positive for the 38 kDa antigen.  Only 
through this drastic method was the antigen liberated, yet the amount was still not visible on a 
Coomassie or silver stain.  Furthermore, the antigen was not stable in SDS sample buffer and 
downstream applications for protein purification were not possible. Not only were the antibodies 
highly specific for the antigen, but they also had a very high affinity for the antigen.  
3.4 Antigen isolated with hydrophobic interaction chromatography 
 A fourth source of antigen was discovered from a bird in a form that was ideal for protein 
purification.  An eclectus parrot, which was seropositive for PDD antigen antibodies, was 
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euthanized for humane reasons.  In addition to tissues routinely obtained for histopathology to 
confirm PDD diagnosis, aqueous and vitreous fluid were both obtained and stored at -80°C 
according to protocol.  This mixture of eye fluids was found to be rich in PDD antigen and 
relatively free of other proteins based on protein staining and western blots.  A new method for 
purification, hydrophobic interaction chromatography, was attempted.  Eye fluid was run through 
the column and the antigen was eluted with PBS after undiluted ACS grade methanol was run 
through the column.  Upon detection of the antigen with western blot, an increase of about 6-8 
kDa of molecular weight occurred (Fig. 5A-B)   The protein on the Coomassie-stained SDS gel 
that corresponded to the positive signal on the western blot was cut out of the gel and analyzed 
by double mass spectroscopy. 
3.5 Mass spectroscopy 
 In-gel protein sample was submitted to Dr William Russell for MS and MS/MS analysis 
at the Laboratory for Biological Mass Spectrometry at Texas A&M University.  The sequence of 
an ABV nucleoprotein isolated from a previous PDD case (M14, scarlet macaw) was kindly 
provided by Dr. Thomas Briese at the Center for Infection and Immunity, Mailman School of 
Public Health, Columbia University.  This sequence was used for comparison to amino acids 
obtained by mass spectroscopy analysis after in-gel trypsin digestion.  Four amino acid 
sequences from the antigen isolated from the ecclectus readily matched the M14 nucleoprotein 
amino acid sequence (Fig. 6).  The isolated antigen was identified as the nucleoprotein of ABV.  
Furthermore, the eye fluid from a PDD affected eclectus parrot was frozen at -80°C at necropsy.  
This fluid was found to be reactive with antibodies from PDD affected birds and was also the 
source of antigen used to identify the antigen as the ABV nucleoprotein.  The fluid was then  
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Figure 5.  Western blot and Coomassie stain of purified antigen.  Coomassie (left, A), and 
corresponding Western blot (right, B) of samples acquired from the ABV nucleoprotein 
purification process using hydrophobic interaction chromatography.  (A) Broad range marker, 
(B) sample collected after eye fluid was added to column, (C) sample collected after column is 
washed with PBS, (D) sample collected after column is washed with 0.5% Tween 20 diluted in 
PBS, (E) sample collected after column is washed a second time with PBS, (F) sample collected 
after undiluted ACS grade methanol is added to column, (G) sample collected after column is 
washed for the last time with PBS.       
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MPPKRQRSPNDQDEEMDSGEPAASRSHFPSLTGAFLQYTQGGVDPHPGIGNEKDIHKNA
VALLDQSRRELYHSVTPSLVFLCLLIPGLHSALLFAGVQRESYLTTPVKQGERLITKTANF
FGEKTMDQELTELQISSIFNHCCSLLIGVVIGSSAKIKAGAEQIKKRFKTLMASINRPGHG
ETANLLSVFNPHEAIDWINAQPWVGSFVLALLTTDFESPGKEFMDQIKLVAGFAQMTTY
TTIKEYLNECMDATLTIPAVALEIKEFLDTTAKLKAEHGDMFKYLGAIRHSDAIKLAPRN
FPNLASAAFYWSKKENPTMAGYRASTIQPGSIVKEAQLARFRRREITRGDDGTTMPPEIA
EVMKLIGVTGFAN 
Figure 6.  Amino acid fragments of isolated nucleoprotein.  Peptide sequences identified from 
MS and MS/MS analysis.  Peptide sequence is from the nucleoprotein of ABV isolated from a 
scarlet macaw that was histopathologically confirmed as PDD positive and was seropositive for 
ABV nucleoprotein. Amino acids highlighted in red are peptide fragments that were successfully 
matched with the protein isolated by hydrophobic interaction chromatography and SDS-PAGE.  
The amino acids highlighted in green represent the predicted cytotoxic T cell epitope as 
identified for BV by Schamel, et al. (2001).  
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taken to Dr. Ross Payne who then took various pictures of the eye fluid using electron 
microscopy.  Results suggest a presence of virus-like particles in the eye fluid (Fig.7).   
4.  Discussion 
 Birds are a valued part of our ecosystem and are an important part of the pet trade.  These 
birds are highly valued not only for their plumage, but also for their longevity.  Proventricular 
dilatation disease has been a problem for bird owners and aviculturalists alike since it was first  
described in the 1970‟s (Clark, 1984).   Researchers have speculated on a variety of viruses that 
could be the etiological agent of PDD with limited success.  A breakthrough came in 2008 and 
2009 with the identification of a newly characterized Borna virus, termed avian Borna virus, and 
its ability to illicit PDD in birds infected with ABV (Gancz et al., 2009; Gray, 2009; Honkavuori 
et al., 2008; Kistler et al., 2008; Tizard, 2009a).  An antigen associated with birds affected with 
PDD, but absent from PDD-negative birds, was identified but not fully characterized at the time 
(Villanueva et al., 2008).  The antigen, present in cell culture and brain homogenate, was 
subjected to different protein purification methods as the extent of the antigen‟s hydrophobicity 
became increasingly apparent.  Different methods were used conjunction to develop a final 
protocol to successfully identify the previously unidentified antigen as the ABV nucleoprotein.  
 Two-dimensional gel electrophoresis was unsuccessful in isolation of the AVB 
nucleoprotein, despite its abundant presence in both the nucleus and cytoplasm of ABV infected 
cells(Ouyang et al., 2009).  A possible explanation for this may be that hydrophobic proteins are 
difficult to detect by such methods (Zuobi-Hasona et al., 2005).  Hydrophobic proteins tend to be 
insoluble during isoelectric focusing and tend to aggregate, particularly membrane associated 
proteins.  It is likely that optimization of ABV nucleoprotein solubility for successful 2-D gel 
electrophoresis will involve experimentation with different detergents such as n-dodecyl-β- 
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Figure 7.  Electron microscopy of possible Avian Borna Virus.  Electron microscopy pictures of 
possible ABV virions from eye fluid from PDD confirmed eclectus parrot.  Courtesy of Dr. Ross 
Payne. 
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maltoside (DDM), or amido sulphobetaine-14 (ASB-14) (Devraj et al., 2009).  It has been 
determined that serum from a PDD affected bird is able to detect the 38 kDa antigen.  Therefore, 
it was expected that the antigen would be detected on a western blot from a 2-D gel using serum 
from a PDD affected bird, even though the protein was not identified after Coomassie staining.  
The western blots from 2-D gels were negative, except for the first time they were performed and 
gave a faint positive signal in the 38 kDa region.  Because of the sensitivity of the assay, it was 
determined that the antigen was not present in the gel.  Another possibility was that the 
chemicals involved in isoelectric focusing interfered with the integrity of the epitope(s) on the 38 
kDa antigen.  However, treatment of the antigen with different detergents, treatment with 2M 
urea, and the stability of the antigen in brain homogenate stored at 4°C after 2 months without 
protease inhibitor made this explanation unlikely.  Attempts to isolate the antigen using antibody 
conjugated beads were only successful after the beads were boiled in SDS sample buffer for 5 
minutes.  From this, it was concluded that the antiserum has a very high avidity for the 38 kDa 
antigen. 
 In order to further characterize the 38 kDa antigen, enzymatic treatment of the antigen 
was performed.  Treatment of the antigen from brain homogenate with n-glycanase resulted in a 
subset of antigen detected at about 36 kDa. N-glycanase enzymatically cleaves off carbohydrate 
residues that are linked to the amino acid asparagine.  These carbohydrate residues are necessary 
for protein folding, conformation and targeting to subcellular regions (Gupta et al., 2009).  This 
is a significant difference since the nucleoprotein of BV is not glycosylated.  This difference 
raises questions as to the difference in function and host range between the ABV and BV and 
their respective nucleoproteins, since the nucleoprotein of BV is not glycosylated (Kobayashi et 
al., 1998).  Previous attempts to isolate ABV nucleoprotein according to methods described by 
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Bause-Niedrig et al. (1992) by ammonium sulfate precipitation were unsuccessful.  ABV 
nucleoprotein shares about 72% homology on the amino acid level to BV nucleoprotein and, 
given the different diseases that these viruses cause to their respective hosts, adds to the 
speculation about the role the nucleoprotein plays in the pathogenesis of ABV (Kistler et al., 
2008).  It is thought that BV spreads along axonal networks, or perhaps through some other form 
of cell to cell spread because of the lack of whole BV virions present in infected cell culture 
(Carbone et al., 1987; Gosztonyi et al., 1993).  Because of the way the RNA of BV is thought to 
be tightly associated with abundant nucleoprotein, and because there is such a robust humoral 
response in birds infected with ABV, the differences in properties between the nucleoproteins 
may account for the differences in disease manifestation (Rudolph et al., 2003).  Second, antigen 
present in brain homogenate was subjected to protease K treatment commonly employed by 
researchers involved in prion research (Biasini et al., 2009).  Earlier accounts of the pathology 
caused by Borna virus disease described some of the cases as resembling spongiform 
encephalitis (Ludwig et al., 1973).  The antigen proved to be susceptible to protease K treatment 
based on western blot analysis.  The fact that PDD is caused by ABV is indisputable.  That ABV 
is the only agent that can cause PDD like symptoms is debatable. There are cases in which 
histopathologically confirmed PDD birds were found to be ABV negative (Kistler et al., 2008; 
Weissenbock et al., 2009a).  Prion disease research is a rapidly growing field and it may be that 
an uncharacterized prion disease circulates in psittacine birds, as it has already be described in 
numerous hosts with potential for trans-species infection (Seuberlich and Zurbriggen, 2010). 
 Hydrophobic interaction chromatography was able to effectively isolate the 38 kDa 
antigen, but there was a significant molecular weight change in the protein which could not be 
explained at the time.  The weight change was an increase of about 5 to 6 kDa from the 38 kDa 
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weight of the originally identified antigen.  This increase in weight may be due to interaction of 
the antigen with some of the reagents used during purification, or perhaps co-purification with an 
unidentified protein.  The antigen was then identified by in-gel digestion followed by MS and 
MS/MS analysis with protein fragments matching several amino acid residues of a sequenced 
ABV.   One of the fragments identified is close to the sequence TELQISSI, which is similar to 
the  CD8 T cell epitope characterized for BV (Schamel et al., 2001).  
 ABV nucleoprotein was isolated and identified from a PDD confirmed bird using the 
bird‟s own serum.  This validates the detection of the ABV nucleoprotein by western blotting as 
a serologic test for the presence of ABV.   Since there are cases of antibodies present in the 
serum of birds that are clinically normal and biopsy negative for PDD, the presence of ABV 
nucleoprotein cannot provide a definitive diagnosis of PDD.  Likewise, a fecal sample from a 
bird that is positive for ABV RNA is not a definitive diagnosis for PDD, raising the issue of a 
carrier state for ABV (Kistler et al., 2009).  The ABV nucleoprotein appears to have hydrophobic 
properties and carbohydrate moieties that make it significantly different from BV nucleoprotein.  
Further analysis of the ABV nucleoprotein will shed light on the pathogenesis and the ensuing 
immune response to this virus. 
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CHAPTER IV 
THE DIAGNOSIS OF PROVENTRICULAR DILATATION DISEASE:  USE OF A 
WESTERN BLOT ASSAY TO DETECT ANTIBODIES AGAINST AVIAN BORNA VIRUS 
 
1. Introduction 
Proventricular dilatation disease (PDD) has caused significant losses in captive birds since the 
early 1980s when it was first recognized in Europe and North America.  PDD affects at least 50 
species of psittacine birds as well as other bird species (Clark, 1984; Gregory, 1994). The 
clinical signs of PDD vary between individuals and species, but in general they exhibit two 
general types of disease.  Some develop neurologic signs such as depression, seizures, ataxia, 
blindness, tremors and incoordination (Steinmetz et al., 2008).  A peripheral neuritis has also 
been reported in some birds involving the sciatic, brachial and vagal nerves (Berhane et al., 
2001). Alternatively, birds may develop gastrointestinal problems such as crop stasis, 
regurgitation, inappetance, and undigested food in feces secondary to damage to the enteric 
nervous system. This damage leads eventually to starvation and death. Death due to circulatory 
collapse or food aspiration is also common. Birds may show neurologic signs or gastrointestinal 
signs or both. It is also suspected that some affected birds may show minor or no clinical signs. 
Definitive diagnosis of PDD is based on detection of a lymphoplasmacytic infiltration in the 
ganglia and nerve plexus, especially the myenteric plexus of the gastrointestinal tract (Schmidt, 
2003). This diagnosis is however made difficult by the variable distribution of lesions in birds. 
For example, in one series of 14 birds (Berhane et al., 2001) lesions were seen in the crop in 43% 
of cases, proventriculus 36%, ventriculus 93%, duodenum 21%, heart 79%, adrenal gland 50%, 
spinal cord 69%, brain 46%, sciatic nerve 58%, brachial nerve 46% and vagus nerve 46%. In 
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another series (Shivaprasad, 1995), 72% of 61 PDD cases had lesions in the crop. While crop 
biopsy has been considered the most definitive diagnostic test, it clearly fails to detect a 
significant portion of the affected population. PDD has long been considered to have an 
infectious etiology. Recently, the use of high-throughput viral screens has enabled investigators 
to identify the presence of a new virus, avian Borna virus (ABV), from several cases of biopsy-
confirmed PDD (Honkavouri et al., 2008; Kistler et al., 2008). Subsequent studies using PCR 
and immunohistochemistry on tissues of affected birds have confirmed the association between 
ABV infection and PDD (Rinder et al., 2009; Weissenbock et al., 2009a). Ouyang et al. (2009) 
have demonstrated the presence of ABV by immunohistochemistry in the central nervous system 
of multiple clinical cases of PDD. PDD has been induced experimentally in cockatiels 
(Nymphicus hollandicus) by Gancz et al. (2009) using infected bird brain and in Patagonian 
conures (Cyanoliseus patagonus) by Gray et al. (2009) using ABV4 passed for six passages in 
duck embryo fibroblasts.  We have also reported on the presence of ABV antigen in the tissues 
of birds with PDD using a Western blot assay (Villanueva et al., 2008).  Borna viruses are 
nonsegmented, negative strand RNA viruses belonging to the family Bornaviridae. Unique 
characteristics of Borna viruses (nuclear localization of transcription, alternative splicing, and a 
differential use of initiation and termination signals) justified their classification into a separate 
family in the order Mononegavirales (Briese et al., 1992). Until recently, only one member of the 
Bornaviridae was known, Borna disease virus (BDV), the cause of a meningoencephalitis in 
horses and sheep largely restricted to central Europe (Ludwig and Bode, 2000).  However 
pyrosequencing of cDNA from the brains of parrots with PDD identified two strains of a novel 
Borna virus (Honkavuori et al., 2008). Using real time PCR, the study confirmed the presence of 
this virus in brain, proventriculus and adrenal gland in three birds with PDD but not in four 
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unaffected birds. Kistler et al. (2008) used a microarray approach to identify a Borna virus 
hybridization signature in five of eight PDD cases and none of eight controls. Using high-
throughput pyrosequencing in combination with conventional PCR cloning and sequencing, 
these investigators were able to recover the complete viral genome sequence of one strain and 
named this virus avian Borna virus. Subsequent investigations have identified seven genotypes 
of this virus (Weissenbock et al., 2009a).  Our ability to culture ABV from cases of PDD 
provides a convenient source of antigen for serologic assays. We have therefore developed a 
Western blot assay that can detect antibodies to ABV in the serum of psittacids. We report here 
on the use of this test as an aid to the diagnosis of PDD and provide further evidence for the 
linkage between PDD and ABV infection.  
2. Materials and Methods 
2.1. Sample material 
Schubot Center birds: The Schubot Center at Texas A&M University had available a collection 
of 23 psittacine birds of seven species donated in the belief that they suffered from or were in 
close contact with cases of PDD. All birds underwent crop biopsy and blood was taken for 
serology.  Birds that died were necropsied and the cause of death was determined.  
Submitted samples: A total of 94 serum samples from 33 species of normal psittacines and 
suspected cases of PDD were submitted by veterinarians who were members of the American 
Association of Avian veterinarians. A confirmed diagnosis of PDD was based on a positive 
necropsy or crop biopsy showing the characteristic lymphoplasmacytic infiltration of the 
neuronal ganglia.  A negative diagnosis was based on a histopathologically negative necropsy or 
biopsy, apparent good health, or clear evidence from necropsy that the bird was suffering from a 
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disease other than PDD. A diagnosis of PDD could not therefore be positively excluded in these 
birds.   
Cockatiels: Fifteen apparently healthy cockatiels (Nymphicus hollandicus) were purchased from 
a single breeder.   
Wild birds: Blood samples were obtained from seven wild scarlet macaws (Ara macao) and one 
mealy Amazon parrot (Amazona farinosa). The samples were taken at the Tambopata research 
center, Peru (_13.1382908,_69.6079608) from birds trapped for radiotelemetry studies, sampled, 
and released immediately afterwards.  
2.2. Antigen preparation 
The antigen preparation used for immunoblotting was a lysate from duck embryo fibroblast 
(DEF) cultures infected with ABV strain M24 originally isolated from a yellow collared macaw 
(Primolius auricollis) and passaged six times in the duck embryo fibroblasts. M24 belongs to 
ABV genotype 4. Cultures were harvested at 5 days post-infection when the ABV-infected or 
normal DEF cells were lysed by freezing and thawing. Recombinant ABV N protein, also used 
as a source of antigen, was generated as follows: RNA was isolated from DEF inoculated with 
the brain homogenates of a PDD-positive bird (M14) using the Qiagen RNeasy Mini kit (Qiagen, 
Hilden, Germany). First strand cDNA was generated using the High Capacity cDNA Reverse 
Transcription Kit and random primers (Applied Biosytems, Foster City, CA, USA). ABV N 
sequence was amplified using primers 50 GCG GTA ACA ACC AAC CAG CAA 30 and 50 
GTT CAT TAG TTT GCR AAT CCR GTT A 30. The amplified region was initially cloned into 
pTOPO vector (Invitrogen, Carlsbad, CA, USA) and sequenced. The N open reading frame was 
then reamplified using forward primer Borna N attB1 (50-AAA AAG CAG GCT TCA CCA 
TGG AAATGC CAC CCA ARA GAC AAA-30) and reverse primer N1-V5 attB2 (50-AGA 
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AAG CTG GGT GTT TGC RAA TCC GST-30), to generate a V5-tagged N product, or Borna 
N1 attB2 (50-AGA AAG CTG GGT TCA TTA GTT TGC RAA TCC G-30). The amplified 
products were moved into pcDNA3.2/V5 DEST (Invitrogen, Carlsbad, CA, USA) by 
recombination-mediated cloning. N expression vectors were transfected into CHO-K1 cells using 
Lipofectamine 2000 (Invitrogen) and after 36–48 h the cells were collected and lysed with RIPA 
buffer (150mM NaCl2, 0.5% DOC, 0.1% SDS, 50mM Tris–HCl, 1% NP-40) by incubation for 5 
min on ice. Expression of V5-tagged N-protein was verified by Western blot with anti-V5 
antibody. In addition, cloned histidine-tagged ABV N (strain 1367; 49 kDa, including tag and 
vector sequence) purified on Ni-NTA-Agarose (Qiagen) was used to confirm the identity of the 
dominant antigen. 
2.3. Western blot assay 
Western blot analysis was used to test the serum or plasma of birds for the presence of ABV-
specific antibodies.  Western blots were performed based on methods originally described by 
Towbin et al. (1979). Infected DEF lysates were standardized to contain 30 µg of protein/lane 
and electrophoresed on 10% polyacrylamide gels. Proteins were transferred to a polyvinylidene 
fluoride (PVDF) in transfer buffer at 100mA for 2 h. Membranes were blocked with PBS pH 7.4 
(Sigma, St. Louis, MO, USA) plus 3% non-fat dry milk and 0.05% Tween 20 at room 
temperature for 2 h.  Test sera were diluted 1:100 in PBS plus 1.5% BSA and 0.05% Tween 20 
and exposed to the antigen blots at room temperature for 2 h. Membranes were rinsed three times 
for 5 min with PBS plus 0.05% Tween 20. Membranes were then incubated with alkaline 
phosphatase labeled goat anti-macaw IgY (Bethyl Laboratories, Montgomery, TX) at a dilution 
of 1:10,000. The membrane was rinsed again and developed for 10 min with 5-bromo-4-chloro-
3-indolyl phosphate/p-nitroblue tetrazolium chloride (BCIP/NBT) from Sigma. Membranes were 
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air dried for about 30 min before reading. Positive control serum was obtained from M24, a 
yellow-collared macaw with clinically, necropsy and histologically confirmed PDD. For control 
purposes, an antibody-negative serum from M21, a blue-and-gold macaw (Ara ararauna) 
histopathologically confirmed to be free of PDD lesions, was used. 
2.4. Fecal PCR assay 
Fresh fecal samples were suspended in 500–750ml of sterile saline on ice. The samples were 
mixed and the solids were pelleted by brief centrifugation at 5000 rpm. RNA was purified from 
the supernatants using either the Ambion MagMAXTM Viral RNA Isolation Kit or the QIAamp 
Viral RNA Mini kit, according to manufacturer‟s recommendations.  Approximately 1mg of 
RNA was used for the synthesis of cDNA (Applied Biosystems1 High Capacity cDNA Reverse 
Transcription Kit) using random primers.  ABV sequences were amplified using primer sets: 
forward (50-CAG ACA GCA CGT CGA GTG AGA-30) and reverse (50- GGC TCT TGG TCT 
GAG ATC ATG GAA-30). The PCR conditions were as follows: initial denaturation, 94 8Cfor 3 
min, followed by 35 cycles of 94 8C, 30 s, 54 8C, 30 s and 72 8C, 20 s followed by a final 
extension of 5 min at 72 8C. Samples were analyzed by agarose gel electrophoresis. 
3. Results 
3.1. Sera from PDD-affected birds recognize ABV N-protein 
Western blot assays using antigen from infected DEF and serum from PDD confirmed birds 
showed that most birds reacted strongly with a single 38–40 kDa protein (Fig. 8). This antigen 
was also found in infected tissues, especially the central nervous system of PDD cases 
(Villanueva et al., 2008). It is expressed in ABV-infected DEF where its quantity increases over 
time. Its molecular weight is compatible with the predicted size of ABV N protein.  Antisera 
reacting with this band reacted with cloned ABV N-protein derived by two different procedures 
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(Fig. 9). The specificity of the reaction to N-protein in tissue cultures was verified by 
preadsorption; antibodies to the N-protein were adsorbed out using an infected DEF lysate but 
not an uninfected DEF lysate (not shown). 
3.2. Western blot assay 
Of the 23 birds from the Schubot Center aviary at Texas A&M University that were crop 
biopsied or necropsied, 11 had characteristic lymphoplasmacytic infiltrates in their ganglia and 
thus were considered to have confirmed PDD.  Of these 11 biopsy/necropsy-positive birds, nine 
(82%) were also seropositive (Table 1). Three of these positive birds were African grey parrots 
in apparent good health.  Twelve birds in the aviary were healthy and had no detectable crop 
lesions so their disease status was unclear.  Of these 12 birds, four (33%) were also seropositive. 
Since it has been determined that crop biopsy is positive in only 40–70% of PDD cases (Berhane 
et al., 2001; Shivaprasad et al., 1995), it is entirely possible that these four seropositive, biopsy-
negative birds were subclinical PDD cases.  Ninety-four serum samples were submitted by 
veterinarians together with clinical and histopathological documentation of their PDD status. Of 
19 birds with necropsy or biopsy-confirmed PDD, 18 (94%) were seropositive. Of 75 „„healthy‟‟ 
birds that did not appear to have PDD, 65 (85%) were seronegative, while 10 were seropositive. 
Based on veterinarian's reports, at least nine of these 10 had been in “contact” with known PDD 
cases.  Serum samples obtained from eight wild psittacids captured at the Tambopata Research 
Center, Peru were negative for antibodies to ABV.      
3.3. Detection of ABV by virus culture or PCR 
PCR was performed on fresh droppings and/or cloacal swabs from the 15 healthy cockatiels. On 
initial testing, fecal PCR was positive in seven of these birds. Two birds were seropositive, one 
fecal PCR-negative and one positive. Subsequent weekly testing of the eight remaining negative 
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Figure 8.  Western blot patterns of serum from infected birds.  The predominant Western blot 
patterns observed using a standard tissue culture-derived antigen preparation from ABV-infected 
(+) or non-infected (−) cultures and exposed to six positive avian sera. Each serum was diluted 
1:100. (A) Nanday conure, (B) Cockatiel, (C) African grey, (D) White cockatoo, (E) DuCorp's 
Cockatoo, and (F) Golden Conure. The arrow denotes the location of ABV N-protein.  
 
 
 
 
 
Figure 9.  Western blot of ABV serum with cloned ABV nucleoprotein.  Comparison of 
reactivity between lane A, crude brain-derived antigen from a confirmed case of PDD; lane B, 
cell lysate from ABV-infected tissue culture-derived; and two cloned ABV N-protein 
preparations, lanes C and D using a single positive macaw serum (M24). The cloned N-protein in 
lane C carries a 7 kDa histidine-tag. The cloned N-protein in lane D is unpurified and grown in 
Chinese hamster ovary (CHO) cells. Lane E consists of a lysate of normal CHO cells. The 
positive serum (M24) used in this immunoblot was adsorbed once with a CHO cell lysate in 
order to reduce the background in lanes D and E. The arrow denotes the location of the ABV N-
protein. 
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Table 1.  Summary of Western Blot Results  
Summary of Western blot results in serum samples from birds housed in the Schubot Center 
aviary and samples submitted by participating veterinarians. Confirmed PDD-positive birds had 
the characteristic histopathological lesions as determine by biopsy or necropsy. 
 
Schubot Center 
confirmed 
positive 
 
Schubot Center 
confirmed 
negative 
 
Submitted 
confirmed 
positive 
 
Submitted 
believed 
“healthy” 
 
Total 
 
Seropositive 9 4 18 10 41 
Seronegative 2 8 1 65 76 
Total 11 12 19 75 117 
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birds by fecal PCR over the next 4 weeks eventually identified an additional six PCR-positive 
birds for a total of 13/15 positive cockatiels. None of these birds changed their serologic status 
during the month-long observation period. In addition, fecal samples from 13 birds housed at the 
Schubot Center aviary were also tested and five were found to be PCR-positive. Thus of 28 fecal 
samples tested, 18 (64%) were positive for fecal ABV (Fig. 10). Six of these 18 birds with 
positive PCR were also seropositive; three of the 10 PCR-negative birds were also seropositive 
(Table 2).  
3.4. Sensitivity and specificity of the serological assay 
When the results of testing serum from both Schubot Center and submitted samples are 
combined, 27 of 30 confirmed PDD cases were seropositive giving a sensitivity of 90%. Of 87 
apparently healthy or non-PDD cases, 14 were seropositive, a specificity of 82% (Table 1). In 
contrast however, in those birds where fecal PCRs were performed (Table 2), only six of 18 
PCR-positive birds were seropositive while three of 10 PCR-negative birds were seropositive 
giving the Western blot procedure an apparent sensitivity of 33% and a specificity of 30%. 
4. Discussion 
Serology has been widely employed in the diagnosis of mammalian Borna virus infection 
although its interpretation has been controversial (Ludwig and Bode, 2000). The most common 
tests employed have been immunofluorescence, ELISA and Western blot assays using 
persistently infected cells, lysates of such cells, or cloned recombinant proteins (Briese et al., 
1995; Hsu et al., 1994; Rott et al., 1991; Thiedemann et al., 1992; Wagner et al., 1968). Much of 
the controversy regarding the significance of serologic assays has centered on the proposed 
association between human neuropsychiatric illness and the presence of antibodies to Borna 
disease virus. This association has generally been disproven, serologic results obtained have not  
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Figure 10.  PCR detection of ABV from bird feces.  Use of PCR for the detection of ABV 
sequences in bird feces. Lanes 1–10 and 16–23: PCR products from fecal samples from healthy 
cockatiels. Lanes 11–15: PCR products from fecal samples from healthy African gray parrots. 
Lanes 2, 4, 11, 12, 13, 19 and 23 show the presence of a band corresponding to the expected 
131 bp fragment. Lanes labeled M contain 100 bp ladder. Lanes labeled C are negative reagent 
controls. The positive control (+) lane is PCR product from the brain of a PDD case. The high 
molecular weight band seen in most fecal samples is a nonspecific product. 
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Table 2.  Summary of Western Blot Results Compared to PCR Results  
Summary of Western blot results for birds from the Schubot Aviary tested by fecal RT-PCR for 
the presence of ABV. 
 
Fecal PCR-positive 
 
Fecal PCR-negative 
 
Total 
 
Seropositive 6 3 9 
Seronegative 12 7 19 
Total 18 10 28 
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been reproducible and are probably low-titred false positive reactions or a result of laboratory 
contamination (Durrwald et al., 2007; Staeheli et al., 2000). It is perhaps appropriate to consider 
the significance of all bornaviral serology with some caution based on this human experience. 
Nevertheless, sera from mammals with confirmed BDV infection and tested by Western 
blotting usually recognize the viral N, and P antigens. Triggered by the susceptibility of chickens 
to experimental infection (Ludwig, 1985), Borna virus infection in birds has been investigated 
previously (Berg et al., 2001; Malkinson et al., 1993). For example, Borna disease virus has been 
detected in the feces of wild birds, notably mallards (Anas platyrhyncos) and jackdaws (Corvus 
monedula) by PCR (Berg et al., 2001). However, the analyzed viral sequences were a match for 
those of mammalian BDV and different from those of the recently characterized ABV. 
In this study, sera from PDD-affected birds reacted strongly with cloned N-protein 
indicating that the immunodominant antigen detected in Western blot assays is the 38 kDa N-
protein of ABV. A comparison of Western blotting results with fecal PCR indicates that the 
Western blot assay does not detect all birds infected with ABV. The survey of cockatiels showed 
that almost all the birds tested had positive fecal PCRs yet were seronegative. The birds appeared 
to be carriers of ABV that showed no clinical symptoms. Repeated testing of these birds also 
indicated that seroconversion does not necessarily occur rapidly after the appearance of ABV 
sequence in feces samples and may not even develop months after ABV is detectable by PCR 
(Unpublished observations). 
Given the absence of a satisfactory antemortem diagnostic test for PDD, it is very 
difficult, if not impossible, to certify any bird free of this disease. Crop biopsy is not only a 
highly insensitive procedure but also a significant surgical procedure not undertaken lightly. 
Furthermore crop biopsy is only positive in 40–70% of PDD cases. It is difficult to justify this 
 63 
 
procedure in clinically healthy, normal birds just to confirm the absence of PDD. Thus a 
“healthy” bird cannot be guaranteed to be free of PDD. As a result, it is very difficult to 
determine the true sensitivity of the Western blot assay. Seropositivity in “healthy” birds is also 
difficult to interpret. As in most other infectious diseases, a population of seropositive healthy 
birds can be expected to exist that may include infected animals about to develop disease or 
recovered animals that are immune to the disease. The relatively few seropositive healthy birds 
observed in this study (16% or less) is compatible with two hypotheses that reflect what we 
know about PDD. First, few birds may survive an infection to become seropositive. Second, 
seropositivity may develop only immediately prior to disease onset–a situation analogous to 
mammalian Borna disease where clinical disease is a result of immunopathologic mechanisms 
(Ludwig and Bode, 2000). Although seropositivity may therefore serve as a useful non-invasive 
diagnostic marker in general, in some cases a more complex scenario may need to be considered. 
Three of our African Grey parrots were crop biopsy positive, seropositive and fecal PCR-positive 
but remained clinically healthy for at least 1 year. However our finding that all eight healthy, 
wild-caught birds from Tambopata, Peru were seronegative provides some assurance that ABV 
is not present in that specific region of the Amazon basin.   
Western blotting represents a significantly improved diagnostic test for PDD when 
compared to the currently available crop biopsy. Given the finding that seronegative birds that 
appear to be shedding the virus as detected by PCR, it is however not feasible to eliminate 
infection from an aviary by the use of Western blotting alone. Western blotting requires only a 
small blood sample and offers in combination with fecal PCR a practical tool for intra-vitam 
diagnosis and surveillance. 
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CHAPTER V 
AVIAN BORNA VIRUS DISCUSSION 
 
  PDD is a disease that is just beginning to be understood.  Since its initial description in 
the early 1970's, it has been the scourge of bird owners because questions of cause, containment 
and prevention remained unanswered.  Recent advances in molecular diagnostics have revealed 
the agent that causes PDD, and continue to be a major factor in pathogen discovery and 
surveillance (Honkavuori et al., 2008; Kistler et al., 2008; Lipkin, 2008). Concordantly, a second 
group employed more traditional methods of pathogen identification, based on the host's immune 
response (Villanueva et al., 2008).  Similar methods had been used to help identify the 
coronavirus responsible for the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak 
(Peiris et al., 2003).  Both molecular and serological methods provide an optimal strategy in the 
diagnosis of ABV.  Shedding of ABV by infected birds has not been adequately studied. 
Conversely, serological tests have not been able to detect all ABV PCR positive animals.  This 
may reflect a difference in antigenic cross-reactivity since strain ABV4 nucleoprotein was used 
for the serological studies.  To date, there have been seven strains identified with varying genetic 
homology (Weissenbock et al., 2009a).  Thus, both tests have their limitations and ideally should 
be performed together for a more definitive diagnosis.   
 When a susceptible host is infected by a pathogen, the host mounts an antibody response 
directed against it.  An exception to this process is when the pathogen causes an acute, fatal 
infection as in the case of Ebola virus.  Antibodies serve to neutralize virus infectivity, target 
virus infected cells for antibody-mediated endocytosis resulting in antigen cross-presentation by 
antigen presenting cells, and targeting cells for complement activation and the membrane attack 
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complex resulting in cell lysis, among other functions (Tizard, 2009b).  In the case of ABV 
infection in birds, the presence of antibodies against the ABV nucleoprotein implies viral 
infection.  However, the function of the antibodies in the course of the disease is unclear.  Two 
different cases of PDD illustrate the complexity of this question.  First, a green winged macaw 
(Ara chloroptera) was housed with other birds that were confirmed PDD positive by crop 
biopsy, serology, and fecal shedding of ABV by PCR analysis.  The macaw was crop biopsy 
negative, seronegative on January 10, 2009, but ABV positive by PCR testing of the feces.  The 
bird was clinically normal otherwise. Approximately one month later, the macaw displayed 
classic PDD symptoms including constant regurgitation, ataxia, lethargy, and crop statsis 
confirmed by Dr. Belcher based on barium fluoroscopy examination.  His serum tested positive 
for the presence of antibodies against ABV nucleoprotein at the time the symptoms were first 
noticed by a student worker who observed the birds daily.  One week after the onset of clinical 
symptoms, the macaw was euthanized due to poor condition and prognosis.  Serum was collected 
upon euthanasia and corresponded to a more robust response against the ABV nucleoprotein.  
Histopathological examination confirmed the macaw was affected with PDD.  At the time of this 
writing, there were three African grey parrots that were seropositive for ABV, shed ABV in their 
feces, and were also crop biopsy positive.  Despite this, the 3 birds remained healthy with little to 
no clinical symptoms for over a year after their original diagnosis.  Given these different 
scenarios, the production of antibodies against ABV may be either protective, or 
immunopathologic.  A carrier state for ABV has been recognized and only adds to the anxiety 
aviculturalists and clinicians share about PDD (Kistler et al., 2009; Lierz et al., 2009; Villanueva 
et al., 2009).  Several factors need to be considered in the different scenarios of ABV infection 
including species difference, ABV strain difference, the effects of a possible autoimmune 
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response, the role of T cells in ABV pathology, and perhaps differences in antibody allotype and 
function.  For example, the presence of certain carbohydrate moieties on the Fc region of IgG 
antibodies has been shown to affect the antibody‟s affinity to different Fcγ receptors, potentially 
targeting the antigen for endocytosis and subsequent antigen presentation (Radaev and Sun, 
2002). Monitoring the avian IgM response during the course of PDD may address some of these 
questions. 
 The role of autoimmunity in PDD pathogenesis is unknown.  A recent paper has 
suggested that BV, and presumably ABV, is able to insert itself into the genome of the host. It 
was also demonstrated that the BV nucleoprotein has significant homology to host proteins 
(Horie et al., 2010).  This finding presents BV pathogenesis in a new perspective.  In the case of 
ABV, the virus may simply become latent, or undergo very low levels of replication.  The 
nucleoprotein may be recognized as self by regulatory T cells and the ensuing immune response 
may simply reflect a breakdown in immunotolerance.  Epitope spreading and molecular mimicry 
may also play a significant role in ABV pathogenesis and eventual progression into PDD.  
Analogous situations occur in the case of Theiler‟s murine encephalitis virus infection in the 
mouse as a model for pathogen-borne multiple sclerosis, or infection of rats with Kilham rat 
virus resulting in autoimmune diabetes (Zipris et al., 2007).  Another factor may be a change in 
the intestinal flora of the infected bird, caused by impaired gastrointestinal motility, resulting in 
an autoimmune response by the host (Chervonsky, 2010).  Autoantibodies have been 
characterized in birds afflicted with PDD.  Anti-ganglioside antibodies were documented in birds 
diagnosed with PDD, leading researchers to believe that PDD may be primarily an autoimmune 
disease (Pesaro, 2009).  Additionally, anti-myelin antibodies were observed in a sun conure 
(Aratinga solstitialis) who remained clinically normal after one year of being diagnosed as 
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seropositive antibodies against ABV (Tizard, 2009a).  Whether these antibodies are a 
consequence of PDD, or they represent a separate underlying condition remains to be 
determined.  It has already been demonstrated that some of these birds have been exposed to a 
number of pathogens, including Theiler‟s murine encephalitis virus, or an agent antigenically 
similar.  The role of autoimmunity in PDD remains unclear, but it is likely that many factors 
aside from the infection of the host with ABV are involved.            
Borna virus is able to infect chickens, ostriches, and has been speculated to be present in 
wild birds including mallards and jackdaws, just as PDD has been recorded in Canada geese and 
ABV has been cultured in chicken embryo fibroblasts (Berg et al., 2001; Daoust et al., 1991; 
Ludwig et al., 1973; Rinder et al., 2009; Verwoerd, 2000). These two viruses are capable of 
infecting similar hosts and yet cause different diseases.  Given that the BV cell receptor has not 
been definitively identified, it seems entirely plausible that a host may be susceptible to both 
ABV and BV.  Infection of a mammalian host with ABV, or infection of a psittacine host, such 
as cockatiels, with BV may be experiments of interest.  Rat C6, Madin-Darbin Canine Kidney 
(MDCK), and Vero cells, traditionally permissive to BV, are not permissive to ABV infection 
(Rinder et al., 2009).  Hosts that may succumb to infection with both viruses may be bats.  
Afterall, 74 different species of bats were shown to carry more than 65 viruses, of which only 3 
viruses were found to be DNA viruses (Calisher et al., 2006).  The propensity for bats to carry 
RNA viruses and their ability to tolerate these viruses remains speculative.  
A protein identified as the ABV nucleoprotein was isolated using a combination of 
protein purification techniques and a serodiagnostic test was developed and implemented with 
results faring better than the standard crop biopsy (Villanueva et al., 2009).   ABV has been 
shown to cause PDD by both natural and experimental infection of previously naïve birds (Gancz 
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et al., 2009; Gray, 2009; Kistler et al., 2009).  Though Koch‟s postulates have been fulfilled, 
important differences between BV and ABV pathogenesis have been observed.  Unlike 
mammalian BV, ABV RNA and nucleoprotein have been found in tissues outside of the nervous 
system (Lierz et al., 2009; Rinder et al., 2009; Villanueva et al., 2008).  In mammalian BV, it is 
speculated that antibodies from the host serve to restrict the virus to nervous tissue (Stitz et al., 
1998a).  Host antibodies against ABV do not seem to inhibit viremia (De Kloet and Dorrestein, 
2009; Villanueva et al., 2009).   In our personal observations and according to others, birds that 
suffered clinically from a PDD-like disease, and in some cases were histologically confirmed 
PDD cases, were not found to harbor ABV (Kistler et al., 2008).   More mysteriously, birds have 
been shown to co-habit with other birds that have died of PDD, and yet remain ABV negative by 
PCR and serology (De Kloet and Dorrestein, 2009; Kistler et al., 2009; Villanueva et al., 2009).  
Indeed, a pair of pionuses (Pionus menstruus), one cagemate was found to be seropositive and 
PCR positive for ABV while the other cagemate remained negative in both tests after over a year 
of testing.  
There are other conditions that may cause proventricular impaction, including lead 
poisoning and mycobacteriosis (Gray, personal communication).  However, that some other 
agent may be able to cause a disease similar to PDD should not be ignored.  A wasting disease 
caused by a prion has not been described in birds.  The avian prion protein has been 
characterized and is found to have about 55% homology to mammalian prion protein.  Avian 
prion protein appears to have copper binding properties and function in cell cycle regulation, but 
has not been associated with an avian wasting disease.  Avian prion protein‟s true function has 
yet to be defined (Atoji and Ishiguro, 2009).  Additionally, emerging molecular tools in disease 
surveillance may uncover other, previously uncharacterized agents present in diseased birds. 
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CHAPTER VI 
INFLUENZA VIRUS 
 
1.  Introduction 
Influenza is responsible for 36,000 deaths in the United States annually (Draghi et al., 
2007).  In the event of a human influenza pandemic, an estimated 20% of the world‟s population 
could become ill resulting in 30 million hospitalizations and a possible 6.5 million deaths 
(Fouchier et al., 2005; Stohr, 2004).  Influenza epidemics are nothing new to humans, but the 
capricious nature of the hemagglutanin antigen allows the virus to re-infect the same populations 
year after year.  Since 1918, there have been 4 pandemics with three different antigenic subtypes:  
the “Spanish” flu of 1918 (H1N1), the “Asian” flu of 1957 (H2N2), the “Hong Kong” flu of 
1968 (H3N2), and the reintroduction of H1N1 in the “Russian” flu of 1977.  Though H2N2 
seems to have disappeared, descendents of the H1N1 and H3N2 pandemic viruses seem to have 
established a permanent presence in the human population.  According to the WHO, since 2003, 
282 people have died out of 471 confirmed cases of H5N1 infection as of January 28, 2010.  
Since 1997, the focus has been mainly on the ability of H5N1-infected chickens to directly infect 
humans, but it is also worth noting that H7 and H9 avian influenza subtypes have also infected 
humans.  An influenza pandemic appears to be a substantial and credible threat at this moment.  
For an influenza pandemic to occur, the H5N1 virus must first successfully transmit from birds 
to humans.  Second, the virus must cause illness and transmit easily between humans.  
Transmission of avian influenza to humans has been a relatively rare phenomenon considering 
the number of people that may have been exposed to sick poultry (Fielding et al., 2007; Vong et 
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al., 2006).  Transmission of H5N1 virus among humans has been even more rare (Ungchusak et 
al., 2005; Vong et al., 2006).  
2.  Pathogenesis and Molecular Biology 
Influenza virus is categorized as either low pathogenic avian influenza (LPAI), or highly 
pathogenic avian influenza (HPAI).  LPAI infection in chickens is characterized as not causing 
any disease, or asymptomatic disease, or a mild disease.  HPAI infection in chickens is typically 
fatal due to broad viral dissemination causing massive cell death leading to organ failure (Pantin-
Jackwood and Swayne, 2009).  Influenza virus is a single-stranded, segmented, negative-sense 
RNA virus that codes for 10 to 11 proteins (Spackman, 2008).  The protein that plays an 
important part in viral tropism is the hemagglutinin (HA) protein.  The HA protein primarily 
attaches to sialic acid in the alpha2, 3 configuration in the avian host.  Influenza viruses that 
infect primarily humans recognize sialic acid in the alpha2,6 configuration (Repik et al., 1994).  
Upon attachment of the HA to the sialic acid, the virus is endocytosed into the cell and HA 
unfolds due to a decrease in pH in the acidic compartment, exposing the fusion protein. At this 
stage, the neuraminidase (NA) protein enzymatically cleaves other sialic acids, thus preventing 
interference viral attachment by other sialic acid moieties.  The drop in pH is facilitated by the 
ion channel protein M2.  M2 has been tested as a potential antigen for vaccine development and 
is also the target of the antiviral amantadine (Chuang et al., 2009; Pei et al., 2009)   The viral 
RNA is then released into the cellular cytoplasm.  Each strand of RNA in the viral genome is 
stabilized and targeted to the nucleus by multiple copies of nucleoprotein via nuclear targeting 
sequences (Wu et al., 2007).  These structures, termed viral ribonucleoprotein complexes, are 
also outfitted with one copy of the polymerase complex consisting of proteins PA, PB1 and PB2 
(Ruigrok and Baudin, 1995).  Upon nuclear localization, replication of viral RNA, as well as 
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anti-sense RNA, is carried out by the polymerase complex. The exact mechanism required to 
switch from viral RNA production to positive sense RNA production for viral proteins remains 
speculative.  Viral RNA is then exported out of the nucleus by primarily by the NXF1 nuclear 
export pathway, at least according to the latest research (Erkmann and Kutay, 2004; Fasken and 
Corbett, 2005; Read and Digard, 2010).  Evidence for nuclear exportation of influenza RNA 
through the CRM1/exportin 1 pathway, the same pathway thought to be utilized by Borna virus 
RNA exportation, has been presented as well (Read and Digard, 2010).  However, the exact 
mechanism of nuclear exportation of the viral ribonucleocomplexes into the cytoplasm for 
translation of viral RNA remains under investigation.  Viral complexes assemble in the 
cytoplasm under the direction of the M1 matrix protein.  The assembled virion then buds from 
the cellular surface enveloped by a lipid bilayer.  In the case of highly pathogenic viruses, the 
HA molecule is already cleaved and ready for subsequent infection into another cell.  This is 
because internal cellular proteases are able to recognize and cleave HA at the multiple basic 
amino acid sequence at the enzymatic cleavage site (Maines et al., 2008).   
3.  Avian Immune Response 
 The immune response to influenza virus infection has proven to be uniform among 
vertebrates, with most of the information coming from infection studies performed on mice 
(Doherty et al., 2006).  Once a highly pathogenic influenza virus infects a chicken, the mean time 
for mortality is between 1.5 to 5.5 days  (Swayne and Kapczynski, 2008). Influenza infection in 
chickens is primarily gastrointestinal, whereas in humans the infection is primarily upper 
respiratory.  The exception is highly pathogenic influenza, in which the host may become 
viremic. Chickens do not have lymph nodes as humans do, but have Peyer‟s patches and mucosal 
lymphoid aggregates.  The paranasal Harderian gland and the Meckel‟s diverticulum act as 
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germinal centers and areas of plasma cell aggregation and the bursa of Fabricius are involved in 
antigen processing (Doherty et al., 2009; Swayne and Kapczynski, 2008).  Influenza viruses first 
invade epithelial cells and then go on to infect other permissive cells, including dendritic cells, as 
in the case of highly pathogenic influenza virus (Swayne and Kapczynski, 2008).  Activation of 
the innate immune system occurs upon infection.  Some of the cytokines first produced upon 
infection include IFNα, as well as TNFα and IFNγ produced by natural killer T cells (Ho et al., 
2008).  Though cytokines are helpful in controlling viral replication and spread, a phenomenon 
known as a “cytokine storm” occurs in which the host produces cornucopia of cytokines with 
unchecked production.  This results in severe inflammation and is often fatal to the host (Perrone 
et al., 2008).  Although not adequately studied, it is thought that the avian immune response is 
similar given the apparent homologues and orthologues of mammalian cytokines contained in the 
avian genome (Kaiser, 2007).  Vaccination of birds against influenza is generally considered 
successful if antibody titer against HA, the major antigenic protein targeted by the humoral 
response, is ≥ 32 based on hemagglutinin inhibition.  This titer is considered a protective 
response and has been shown to prevent viral shedding upon influenza re-infection in birds (Lee 
et al., 2004).      
Adaptive immunity plays a critical role in viral clearance from the host. Cytotoxic T cells 
effectively destroy influenza infected cells by the use of granzymes and perforin, with the aid of 
IFNγ and TNFα (Doherty et al., 2009; Thomas et al., 2006).  T helper cells have also been shown 
to aid in viral clearance, but to a lesser degree.  In humans, T helper cells assist in directing B 
cells to produce different IgG isotypes.  In particular, IgG2a has been shown to be an effective 
antibody for influenza virus clearance(Brown et al., 2004).  However, chickens are as of yet only 
known to have one isotype of IgY (Tizard, 2009b).  Chickens have been shown to have dendritic 
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cells that function in a manner very similar to human dendritic cells, and indeed other 
lymphocytes that function in a similar manner to that of their mammalian counterparts (Erf, 
2004; Wu et al., 2010).  Recently, a T cell epitope, recognized by both CD4 and CD8 T cells was 
described in the avian response to influenza H5 protein.  This is the first T cell epitope of 
influenza viruse recognized by chicken T cells, corresponding to H5246-260, a generally conserved 
amino acid sequence among influenza HA proteins (Haghighi et al., 2009).    
4.  Animals as “Mixing Vessels”  
 Another potential source of pandemic influenza virus is the pig.  Pigs have been proposed 
as a “mixing vessel” for genetic recombination of avian and human influenza viruses (Ito et al., 
1998; Kida et al., 1994; Van Reeth, 2007).  One of the primary reasons for this theory is that the 
trachea of a pig contains both NeuAcα2,3Gal (α2,3 sialic acid) and NeuAcα2,6Gal (α2,6 sialic 
acid) receptors recognized by avian influenza and human influenza viruses, respectively (Repik 
et al., 1994). Human infections with swine influenza are a rare event given the abundance of α2,6 
sialic acid receptors in the porcine trachea and epithelial cells from the upper respiratory tract in 
humans (Komadina et al., 2007; Van Reeth, 2007).  It remains to be determined what the 
biological barriers, other than receptor specificity, are that prevent the influenza virus from 
transmitting freely between species. Currently, three main influenza subtypes are circulating in 
pigs: H1N1, H1N2, and H3N2 (Gourreau et al., 1994; Jung et al., 2007). 
Many factors may account for interspecies transmission of influenza virus, including 
virus receptor specificity, immune status, the correct combination of genes in a virion, and 
perhaps a genetic susceptibility to infection.  It may be posited as to why it is that interspecies 
transmission of influenza virus does not happen more often.  It is thought that barriers which 
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prevent interspecies transmission of influenza virus may be exploited to develop a more 
efficacious vaccine. 
5.  Anti-gal Antibodies  
In 1984, Galili and colleagues published results which described a new type of human 
natural antibody specific for the Galα1,3Galβ1,4GlcNAc (alpha-gal) eptiope. Galili and 
colleagues named this antibody “anti-gal” (Galili et al., 1985; Galili et al., 1984). It was 
determined that Old World primates and humans produce anti-gal whereas New World primates 
and nonprimate mammals do not produce the antibody, but express the alpha-gal epitope. It is 
hypothesized that the α1,3galactosyltransferase gene, which produces the enzyme responsible for 
alpha-gal production, was inactivated in Old World primates about 20 million years ago.  This 
phenomenon may have given these animals an immunological advantage against a pathogen 
(Galili et al., 1987; Galili et al., 1988b).   
Like other natural antibodies, such as anti-blood group antibodies, anti-gal is thought to 
be produced in response to normal bacterial flora of the gut (Galili et al., 1988a; Springer and 
Horton, 1969; Wiener, 1951).  Though the alpha-gal epitope is not found in normal human 
tissues, it is expressed on senescent red blood cells.  It is thought the purpose of anti-gal is to 
target senescent red blood cells for lysis. Based on the structures below, one can see the 
similarity that the alpha-gal epitope shares with blood group epitopes.                                              
   What sets apart anti-gal from the blood group antibodies is that it‟s found as IgG, IgM, 
and IgA isotypes as opposed to mainly IgM isotype of blood group antibodies.  Another unique 
feature of this natural antibody is that it is found in high concentrations in normal serum.  Anti-
gal makes up about 1% of total IgG, or about 40-100 µg/ml in all four classes(Galili, 2006; Galili 
et al., 1984).  Individuals with blood type A or O produce about 85% of their anti-B antibodies as 
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anti-gal antibodies, so actual anti-gal IgG concentrations may vary significantly.  Anti-gal IgM is 
found in similar titers as IgG, but levels vary greatly with individuals, just as they do with serum 
anti-gal IgG. In some studies, there is no significant difference between IgG and IgM levels in 
serum (Diaz et al., 2003; Hamadeh et al., 1995b; Teranishi et al., 2002).  IgA anti-gal levels in 
serum are low, but are found in significant amounts in whole colostrum, milk, and saliva 
(Hamadeh et al., 1995b).  
 The reason for the presence of this antibody in such high titers is unknown.  Of particular 
note is the interaction of anti-gal with microbes.  It has been found that anti-gal is able to bind 
the LPS of Escherichia coli and Serratia marcescens in normal gut flora and inhibits 
complement activation against these microbes.  When the antibody binds the LPS of pathogenic 
E. coli, anti-gal is able to activate complement and effectively lyse the bacterium (Hamadeh et 
al., 1992).  Anti-gal can also bind to pili of the human pathogen Neisseria meningitidis, but will 
not lyse the bacterium with complement.  In this case, anti-gal IgA is thought to play a role in 
bacterial pathogenesis by inhibiting complement activation (Hamadeh et al., 1995a).  The 
erythrocytic stages of Plasmodium falciparum malaria were found to express the alpha-gal 
epitope.  As a result, people with known malaria infections were found to have elevated levels of 
anti-gal antibodies (Ravindran et al., 1988).  It was also reported that patients infected with 
human papillomavirus were found to express elevated amounts of anti-gal in their cervical 
mucus (Hernandez et al., 2002).  Based on these findings, anti-gal is able to provide 
immunogenic tolerance to normal flora and aids in the clearance of some pathogens.   
 Studies have shown that normal human serum is able to inactivate viruses that express the 
alpha-gal epitope.  Therefore, anti-gal is thought to serve as a potential barrier against viral 
infections.   Viruses passaged through cells expressing the alpha-gal epitope were found to be 
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inactivated by normal human serum. These viruses include pseudorabies virus, eastern equine 
encephalitis virus, and porcine endogenous retrovirus, among others (Hayashi et al., 2004; Quinn 
et al., 2004; Repik et al., 1994).  It is of interest to determine if this phenomenon occurs with 
influenza virus.  Galili and colleagues found that influenza virus hemagglutinin (HA) 
glycoprotein is able to accept alpha-gal residues and antibody complexes with alpha-gal-HA 
were formed.  Furthermore, antigen presentation was enhanced if HA contained the alpha-gal 
epitope (Galili et al., 1996; Henion et al., 1997).     
Incorporation of alpha-gal epitopes in vaccines are not a novel concept.  Experimental 
tumor vaccines and HIV vaccines with alpha-gal have produced higher antibody titers than 
vaccines without the alpha-gal epitope.  Both these vaccines were tested in the alpha-gal “knock 
out” mouse model (Abdel-Motal et al., 2006; Abdel-Motal et al., 2009b; Galili et al., 2007).  
Recently, alpha-gal was enzymatically conjugated onto the HA of PR8 H1N1 virus and used as a 
vaccine in the alpha-gal “knock out” mouse.  Results confirmed that mice vaccinated with alpha-
gal PR8 HA produced a higher amount of antibodies against HA, as compared to mice 
vaccinated with PR8 HA without alpha-gal (Abdel-Motal et al., 2007).  It is of interest to 
determine the efficacy of an influenza virus vaccine with respect to incorporation of the alpha-
gal epitope.  Though mice are not natural hosts of influenza virus, birds are known to be 
naturally infected with influenza virus.  Consequently, anti-gal antibodies have been described in 
chickens (McKenzie et al., 1999). Therefore, chickens may serve as a better model for the 
enhancement of the immune response to an alpha-gal influenza vaccine through interaction with 
anti-gal. These results may encourage influenza vaccine production in tissue culture in order 
circumvent the current shortcomings of vaccine production in hen‟s eggs. 
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CHAPTER VII 
ENHANCEMENT OF HUMORAL IMMUNE RESPONSE TO ALPHA-GAL 
INFLUENZA VACCINE  
 
1.  Introduction 
Influenza is an RNA virus responsible for upper-respiratory infections in humans and 
subsequently thousands of hospitalizations, including 36,000 deaths annually in the United States 
alone (Draghi et al., 2007; Fouchier et al., 2005).  The capricious nature of the virus, making it 
hard to predict the nature of the next influenza pandemic, is best exemplified by the current 
H1N1 “swine flu” pandemic.  Previous attention was focused on the ability of highly pathogenic 
H5N1 avian influenza to be the source of the next human influenza pandemic, that an H1N1 
virus of swine origin swiftly became established in the human population.  Fortunately, this virus 
does not appear to have the potential to become highly pathogenic according to current 
definitions, and previous exposure to H1 antigen seems to confer some degree of immunity 
despite the significant amino acid divergence between 2009 pandemic H1 and previous H1 
antigens (Herfst et al., 2010; Saxena et al., 2009; Vincent et al., 2010).  These findings only 
reiterate the importance of vaccination as a means of infection prevention.     
The need for an influenza vaccine that elicits a robust humoral and adaptive immune response is 
needed to curb the effects of seasonal influenza infection.  Though various types of influenza 
vaccines are available, there are two primary sources of vaccine production: eggs and cell 
culture.  Though influenza virus grown very well and to high numbers in eggs, there are a few 
disadvantages to vaccine production in eggs.  Production is dependent on the health of available 
chickens and their egg production, the management of the eggs before and after virus 
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inoculation, and the co-purification of egg products that some people may be allergic to.  An 
alternative is cell culture based influenza vaccine production.  Indeed, the European Union has 
already approved influenza vaccine produced from MDCK cell culture.   
Another benefit to producing the MDCK-based influenza, although perhaps unintended, is the 
presence of the alpha-gal carbohydrate epitope.  This carbohydrate epitope is the target of the 
natural anti-gal antibody that constitutes about 1% of circulating IgG in old world primates, 
including humans (Galili et al., 1984; Galili et al., 1988b).  It is postulated that intestinal flora 
assist in the development of this natural antibody, similar to blood group antibodies (Galili et al., 
1988a; Springer and Horton, 1969).  These antibodies have also been described in newborns, 
suggesting maternal transfer of these antibodies (Teranishi et al., 2002).  Anti-gal has proven to 
pose a great barrier to successful xenotransplantation (Galili, 2006).  Because of this, anti-gal has 
been exploited to enhance the immune response to vaccines that incorporate the alpha-gal 
epitope.  Alpha-gal has been incorporated into endogenous tumor vaccines as a method to break 
immunological tolerance and activate the immune system to perceive tumor associated antigens 
as foreign (Abdel-Motal et al., 2009b; Galili et al., 2007).  Alpha-gal has also been enzymatically 
added to influenza virions to enhance the immune response to this virus, compared to virus that 
does not possess the alpha-gal epitope (Abdel-Motal et al., 2007; Galili et al., 1996; Henion et 
al., 1997).  The reasoning behind this phenomenon is that anti-gal is able to bind antigens that 
contain the alpha-gal and target them directly to antigen presenting cells via Fc receptors.  
Internalization of vaccines in such a manner increases the processing and presentation of 
antigens to activate T cells (Abdel-Motal et al., 2009c). 
In this study, chickens were used as the animal model to test the ability of anti-gal to enhance the 
immune response against influenza vaccines due to their natural production of anti-gal antibodies 
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(McKenzie et al., 1999).  Chickens have dendritic cells that are thought to function in the same 
manner as human dendritic cells and even bear the same molecular markers (Wu et al., 2010).  
Subsequently, chickens are also naturally susceptible to influenza infection, unlike the alpha-gal 
“knock out” mice used in previous studies (Abdel-Motal et al., 2007).  Influenza H5N3 vaccines 
were formulated with and without alpha-gal epitopes to determine what effect alpha-gal would 
have in enhancement of the immune response against influenza antigen.     
2.  Materials and Methods 
2.1 Affinity chromatography 
Serum from human male (blood type AB), or pooled serum from chickens (Sigma) was thawed.  
A 2 ml melibiose column on Foxy® Jr fraction collector was set up according to operator‟s 
manual and rinsed with 200 ml TN150 buffer (0.025M Tris, 0.150M NaCl in dH20).  Serum was 
then diluted 1:2 with TN 150 buffer and 0.2µ sterile filtered.  Diluted serum was run through the 
column, then rinsed with 200 ml TN500 buffer (0.5M NaCl) followed by another rinse with 200 
ml TN150 buffer. Anti-gal antibody was eluted with 200mM melibiose (Sigma) and fractions 
were collected.  Based on the UV readout graph, necessary fractions were collected to run on a 
10% SDS gel and the rest saved at -80°C.  Fractions were pooled, dialyzed, and the final product 
was run on 10% SDS gel.  NaN3 was added to the anti-gal antibody solution to a final 
concentration of 0.02% and stored at -80ºC. 
2.2 SDS-PAGE 
SDS-PAGE gels were run based on methods originally described by Laemmli (Laemmli, 1970). 
Briefly, 10% polyacrylamide 0.75mm thick minigels were made in the lab using the protocol, 
glass plates, and gel assembly kit from BioRad Biotechnologies, Hercules, CA USA.  Protein 
samples were mixed 1:1 with Laemmli reducing sample buffer (BioRad, Hercules, CA USA) and 
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boiled in water for 5 minutes.  Twenty microliters of sample were loaded into each well.  A 
broad range pre-stained ladder (BioRad, Hercules, CA USA) served as the molecular weight 
standard. Gels were run in denaturing running buffer at 40 milliAmps for 45 minutes, or until the 
sample buffer reached the bottom of the gel. 
2.3 Western blot 
Western blots were performed based on methods originally described by Towbin et al., 1979.  
Briefly, SDS gels were transferred onto a polyvinylidene fluoride (PVDF) membrane in transfer 
buffer at 100 milliAmps for 2 hours.  The PVDF membranes containing the protein samples were 
then  blocked with PBS (Sigma, St. Louis, Missouri USA) pH 7.4 plus 3% non-fat dry milk and 
0.05% Tween 20 shaking at room temperature for 2 hours.  Next, serum, or purified antibody 
were diluted in PBS plus 1.5% BSA and 0.05% Tween 20 at 1:100.  Membranes were washed 3 
times for 5 minutes with PBS plus 0.05% Tween 20.  Next, the membranes were incubated with 
alkaline phosphatase labeled rabbit-anti-chicken (Bethyl Laboratories) diluted in the same 
solution as the primary antibody at 1:10,000.  Membranes were washed again 3 times and 
developed for 10 minutes with 5-bromo-4-chloro-3-indolyl phosphate/p-nitroblue tetrazolium 
chloride (BCIP/NBT) from Sigma.  Membranes were air dried for about 30 minutes to determine 
final results. 
2.4 Rabbit erythrocyte hemagglutination 
SPF New Zealand White rabbit erythrocytes are obtained from LARR courtesy of Dr. Vincent 
Gresham or Andrea Taylor.  Erythrocytes were washed twice with PBS and centrifuged at 930 X 
g (2000RPM) at 4ºC using the Allegra® X-15R centrifuge.  Cells were then stored at 4ºC until 
further use.  Cells were kept for 1 week and then discarded if not used.   Antibody stock, or 
whole serum is diluted 1:10 in PBS prior to performing assay.  On a 96-well V-bottom microtiter 
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plate, 50µl of PBS were added to serially dilute the stock antibody solution 2-fold in duplicate.  
Two wells served as controls (PBS + RBC) for each sample.  Once serial dilutions were made, 
50 µl of rabbit red blood cells were added to each well.  Hemagglutination titer was determined 
once the cells in the control wells settled at the bottom. For hemagglutination inhibition, 
antibody was incubated with melibiose for 30 minutes at room temperature before an equal 
amount of erythrocytes were added. 
2.5 Vaccination of chickens with inactivated virus 
Forty chickens at 2 weeks age were obtained from the A&M Poultry Science Center.  The 
influenza virus A/Singapore/97 H5N3 was used for the vaccines.  Chickens were divided into 4 
groups based on the type of vaccine they received: alpha-gal influenza, alpha-galactosidase 
treated MDCK-grown influenza, PBS with alpha-galactosidase, and PBS.  Each chicken received 
approximately 0.09 mg of HA, according to previous recommendation (Maas et al., 2009).  Virus 
grown in MDCK cells were subjected to alpha-galactosidase (Sigma, St. Louis, MO USA) with 
3µl of 5% enzyme stock solution in PBS.  This is a modified method of previously described 
methods (Luo et al., 1999).  All viral vaccines were inactivated with formalin based on protocols 
established by DelSite Biotechnologies, Inc and were administered IM in the left breast muscle 
at 3 weeks age.  Chickens were bled from the jugular vein to check serum anti-gal titers. 
3. Results 
3.1 Purification of anti-gal antibodies 
Anti-gal antibodies from adult chicken serum (Sigma, St. Louis, MO USA) were purified using a 
melibiose (gal-alpha1,6gal) column with the Foxy® Jr fraction collector at room temperature.  
Based on UV output, fractions were collected that contained the largest concentrations of 
protein.  Samples of the fractions were run on SDS-PAGE and western blots were performed 
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with gal-alpha1,3gal-conjugated bovine serum albumin proteins as a positive control.  Western 
blot results were positive for anti-gal-alpha1,3gal antibodies with SDS-PAGE indicating a 
relatively clean protein preparation of primarily IgY antibodies.  These antibodies were used as a 
positive control for further experiments.     
3.2 Alpha-gal epitopes on MDCK passaged virus 
Influenza virus A/Singapore/97 H5N3 was grown in Madin-Darby Canine Kidney (MDCK) cells 
in the presence of trypsin, according to protocols established by DelSite Biotechnologies, Inc.  
Briefly, MDCK cells were grown in roller bottles with serum free media at 37°C.  Cells were 
then checked for approximately 90% confluency, the old media was discarded and new media 
was added with freshly thawed seed stock virus and trypsin.  Cells were incubated at 33°C and 
monitored for cytopathic effect, then harvested at approximately 48 hours.  Virus was then 
purified by Dr. Guo Jianhua according to protocols established by DelSite Biotechnologies, Inc.  
Influenza virus was then inactivated in formalin at 4°C for over 48 hours.  Alpha-gal epitopes 
were determined to be present on the virus by western blot.  Furthermore, alpha-gal epitopes 
were removed by alpha-galactosidase from green coffee bean according to previously described 
methods (Luo et al., 1999).  Anti-gal antibodies previously reactive with MDCK-passaged 
influenza virus were no longer reactive upon addition of alpha-galactosidase (Fig. 11).  As a 
control, anti-gal antibodies were not reactive with the alpha-galactosidase enzyme.  A successful 
method of determining the effect of anti-gal on enhancing the humoral immune response had 
been developed.  The only difference between these two vaccines was the absence of alpha-gal 
epitope. 
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Figure 11. Western blot of influenza vaccines administered to chickens.  Western blots of 
vaccines administered to White Leghorn chicks at 3 weeks of age.  Virus for vaccine was grown 
in MDCK cells.  A, western blot of vaccines treated with alpha-galactosidase enzyme and probed 
with chicken anti-gal antibodies to confirm removal of alpha-gal moieties from HA protein.  B, 
vaccines with alpha-gal moieties reactive with chicken anti-gal on HA glycoprotein (arrow).  C, 
coomassie stain of vaccines, without enzyme, administered to chickens.  
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3.3 Vaccination of chickens  
Day-old white leghorn chicks were collected from the Poultry Center at Texas A&M 
University and placed in BSL-2 isolation buildings.  Chicks were fed starter feed and given water 
ad-libitum.  Chicks were housed in hanging cages (10 per group) which were cleaned and 
monitored daily.  Chicks were bleed at 3 weeks and subsequently vaccinated with either alpha-
gal H5N3, H5N3, alpha-galactosidase enzyme, or PBS.  Chicks were subsequently bled at 5 
weeks, at 9 weeks and again at 11 weeks.  A second booster vaccine was given at 9 weeks of age 
to determine boosting effect. 
3.4 Determination of anti-gal titers in chickens       
Serum collected from chicks at 3 weeks of age contained no traces of anti-gal antibodies based 
on rabbit erythrocyte agglutination.  Since there were extra chicks, 3 were terminally bled and 
their serum was pooled.  The pooled serum was subjected to affinity chromatography and 
fractionation.  All fractions collected were negative for anti-gal based on SDS-PAGE and 
western blot.  Interestingly, some sera that were not heat inactivated were found to agglutinate 
rabbit erythrocytes at 2 HA units. At week 5, most chicks were found to have anti-gal at titers 
ranging from 8 to 64 HA units.  One chick still contained no anti-gal in its serum while 3 chicks 
contained 64 HA units.  Anti-gal titers from 32 to 64 HA units among all chicks were established 
by week 9. 
3.5 Virus neutralization assay 
Crucially, virus neutralization assay was unable to be performed because of time and resource 
constraints.  Aside from the fact that anti-gal was not present in chicks at the time of vaccination, 
live H5N3 virus was unable to be worked with because it would require 5 days of no interaction 
with avian species.  
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4. Discussion 
Though chicken vaccination programs have been largely successful because of the broad cross-
reactivity of anti-HA antibodies in chickens, the challenge for a more robust influenza vaccine in 
humans remains (Doherty et al., 2006; Swayne and Kapczynski, 2008).  Alpha-gal epitopes have 
proven to be beneficial in various vaccine strategies where a more vigorous immune response is 
warranted.  This has proven particularly true for endogenous tumor vaccines containing alpha-
gal epitopes in which tumor associated antigens successfully incorporate the carbohydrate 
epitope and trigger an immune response against the previously tolerated tumor (Abdel-Motal et 
al., 2009b; Galili et al., 2007).  This strategy has been further extended into development of more 
effective HIV and influenza vaccines (Abdel-Motal et al., 2006; Abdel-Motal et al., 2007; 
Abdel-Motal et al., 2009a).  However, the shortcoming of these experiments is that the alpha-gal 
“knock-out” mouse is not a natural host to either HIV or influenza.  Although anti-gal titers 
comparable to human anti-gal titers amounting to 1% of total IgG are achieved, mice do not have 
the same repertoire of IgG isotypes that humans have.  The chicken presents a better animal 
model for the effects alpha-gal epitope would have on enhancement of the immune response.  
The chicken is not only a natural host of influenza virus, but it has an immune system that is 
found to function in a similar manner to the human immune system and naturally develops anti-
gal antibodies (Erf, 2004; Kaiser, 2007; McKenzie et al., 1999; Wu et al., 2010). 
Anti-gal antibodies were not self-reactive (results not shown), but a vaccine with just the enzyme 
was administered to in order to dismiss the question of a potential adjuvant effect of the enzyme.  
Anti-gal titers were unable to develop by 3 weeks at the time of vaccination.  This may be 
because the chickens were kept in an environment that did not allow their intestinal flora to 
develop properly.  Indeed, development of a proper intestinal flora depends not only on 
 86 
 
environment, but in this case, the development of anti-gal antibodies in chickens depends also on 
diet (Cotter and Van Eerden, 2006).  In this regard, the experiment should be repeated with 
chickens that are housed in an environment that is more natural to their upbringing.  This would, 
of course present more variables into the experiment.  A second option would be to vaccinate 
chickens at 5 weeks to determine the effects of alpha-gal vaccines.  However, by this time most 
chickens are already consumed, and so the applications may only be beneficial to humans.  
This experiment must be repeated with special attention to anti-gal development in chickens.  As 
demonstrated by three week old chicks that were terminally bled and found lacking anti-gal 
antibodies, it does not appear that these antibodies are transferred maternally.  That serum which 
is not heat inactivated is able to agglutinate rabbit erythrocytes suggests the presence of lectins 
able to bind alpha-gal or perhaps another carbohydrate moiety on these red blood cells. 
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CHAPTER VIII 
SUMMARY  
 
Avian Borna Virus and Influenza are both considered important pathogens of birds.  PDD 
has been a problem for aviculturalists and pet owners alike since the 1970s.  Until recently, an 
etiological agent had not been identified and therefore, a diagnostic test could not be established.  
In these experiments, an antigen common to these diseased birds was found, isolated, identified, 
and a resulting serodiagnostic test was developed.  This serodiagnostic test may be used in 
conjunction with PCR tests to more accurately determine the presence of ABV in birds. 
Secondly, the effect of a carbohydrate epitope incorporated into influenza vaccine was 
tested.  Chickens produce natural antibodies against the anti-gal epitope.  It was thought that this 
would result in an enhanced humoral immune response by directly targeting these antigens to 
antigen presenting cells.  However, it was not anticipated that these chickens would not be 
producing anti-gal at the time of vaccination.  Although influenza vaccines that differed only in 
alpha-gal epitope were produced, the ability for this epitope to enhance the humoral immune 
response in chickens could not be determined. 
Birds are an important part of many ecological processes including seed dispersal and 
insect control.  Not to mention, they are also an important source of food.  Measures must be 
taken to insure that these animals are protected. 
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